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Protein-protein interactions (PPIs) are crucial to most biological processes and 
activities. Large-scale PPI screening has been applied to model organisms as well as 
to human cells. Two approaches have been used extensively in high-throughput PPI 
studies: (i) the Yeast Two-Hybrid (Y2H) assay (a bottom-up method), and (ii) the 
tandem affinity purification (TAP) (a top-down method). However, a close 
examination of both techniques revealed issues that limit their effectiveness. Thus, it 
is important to develop new methods that can bridge the gap between the Y2H and 
the TAP. In this thesis, two approaches were developed to meet this need.  
 
The first approach was a photoaffinity labeling tool, which was based on a photo-
caged reactive intermediate para-quinone methide (pQM) to study protein-peptide 
associations. This system was developed and optimized by using the interaction 
  
between catPTP1Bm and the EGFR peptide as a test case. Highly specific protein 
labeling was achieved, and mass spectrometry (MS) was used to identify the 
crosslinked site on the target protein. Interestingly, two peptides from catPTP1Bm 
detected by MS were found close to the enzyme-substrate binding interface in the 
three-dimensional structure of the complex, which demonstrated this method might 
be useful for the analysis of protein complex conformation.  
 
The second approach, named “PCA plus”, took advantage of a technique referred to 
as “Protein-fragment Complementation Assay (PCA)”. A hydrolysis-deficient mutant 
β-lactamase (E166N) was used, which enabled interacting protein labeling in live 
cells. With this modification, the PCA plus method realized live cell imaging with 
subcellular resolution. Fluorescent microscopy and flow cytometry analysis 
demonstrated its potential applications. In addition, a new β-lactamase substrate was 
developed for the PCA plus method and was applied to enable purification, from 
living cells, of prey protein interacting with a bait protein. The observed enrichment 
of interacting partners suggested the system could be used for high-throughput PPI 
screening. Moreover, this method could also be useful for the characterization of low 
affinity and transient PPIs because of its capacity on labeling interacting protein 
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Introduction to Protein-Protein Interactions and Experimental Approaches Used to 
Study Them 
Overview 
Selective interactions between molecules play essential roles in biological system. 
Among these interactions are numerous protein-protein interactions (PPIs). For example, 
the structure and function of ribosome in E. coli is dependent on the interaction of 56 
proteins (Nakao et al, 2004). Transcription in eukaryotes provides another example: it 
involves interactions among RNA polymerase II, five general transcription factors, a 20-
protein complex called Mediator, and hundreds of transcription regulators (Kim et al, 
1994). As another example, it was recently reported that the eukaryotic nuclear pore 
complex (NPC), one of the largest molecular machines, is assembled by about 30 
nucleoporins (Elad et al, 2009). Besides these general functions, PPIs also play pivotal 
roles in specific biological processes. For example, in bacterial two-component signaling 
system, modular domains can adapt different conformational states to enable diverse 
regulatory mechanisms through stablizing or destablizing PPIs (Gao & Stock, 2009). In 
the innate immune system of mammals, adaptor proteins, such as Myd88, can activate 
different signaling pathways by selectively interacting with different effector proteins. On 
average, one protein interacts with five other proteins in a cell (Piehler, 2005). Therefore, 
characterizing PPIs is critical to understanding biological systems. In addition, because 
protein interactions can be highly dynamic as a result of spatial and temporal changes 
inside a cell, new characterization techniques that can detect diverse interactions could be 





underlining PPI and experimental approaches used to study PPI. This review is then 
followed by an introduction to techniques that are involved in our method development. 
 
Diversity of PPIs 
PPIs are usually classified based on the affinity of their interaction, the lifetime of the 
complex, and the abundance of the interacting partners. Therefore, any given PPI might 
be referred to as: a strong or weak interaction, a stable or transient interaction, or a high 
or low abundance interaction. The affinity between two interacting proteins can be 
described quantitatively by the dissociation constant (Kd), which is associated to the free 
energy change of a protein interaction event. Usually, a PPI with a Kd higher than 10-6 M 
is considered to be a low affinity or weak interaction (Vaynberg et al, 2005). It is 
noteworthy that the affinity and the lifetime of a protein complex are the two sides of a 
coin, as Kd can also be determined by the ratio koff/kon. kon is the association rate constant 
and koff is the dissociation rate constant (Vaynberg & Qin, 2006). Accordingly, the 
affinity and the lifetime of a complex are often inversely related. High affinity complexes 
usually have a long lifetime, while low affinity complexes usually are short-lived. 
Typically, a low affinity complex (Kd 10-5~10-6 M) will dissociate relatively quickly (half 
life of 0.1-1 s), and so it will be a transient PPI, continuously dissociating and reforming. 
By contrast, typical stable PPIs have binding affinities of 10–12–10–9 M and half-life range 
of 12 min–19 h (Rudolph, 2007). PPI events are also related to the abundance of protein, 
defining low abundance and high abundance PPI. Protein concentrations vary 
dramatically inside cells. For example, in yeast, the absolute protein copy number ranges 





are very low (less than 1nM), so some binary PPIs detected in vitro are considered 
nonspecific and therefore neglected if there is no further physiological evidence 
(Vaynberg et al, 2005). 
 
The nature of PPIs 
PPI modules 
Protein domains and peptides are the functional units responsible for PPIs. Accordingly, 
PPIs have two forms: domain-domain association or domain-peptide association 
depending on the type of their interfaces. Although protein domains have highly 
diversified functions, many of them are exclusively dedicated to PPIs in a pathway 
related to specific cellular events. For example, the Death Domains (DDs) are more likely 
to mediate PPIs in an apoptosis signaling pathway (Hofmann & Tschopp, 1995). The 
Polyglutamine (PolyQ) domains are mostly involved in the interaction between 
transcriptional regulators (Palhan et al, 2005). The WD40 repeat domains are well known 
in cytoskeleton assembly and transcriptional activation by forming a platform for multi-
protein assembly (Orlicky et al, 2003). The Leucine zipper domains can interact with 
each other to form two-, three-or four-stranded coiled coils (Harbury et al, 1993). All 
these are examples of domain-domain based PPIs involving either heterogeneous or 
homogeneous associations. Because of the importance of domain-domain interactions, 
some large-scale PPI maps have been constructed for them (Boxem et al, 2008; Prieto & 
De Las Rivas, 2009). Besides domain-domain interactions, domain-peptide interactions 
also govern critical cellular activities. There are also many examples in this category. The 





al, 2009). The PDZ domains are important interaction modules in cytoskeleton related 
signaling, which can bind the C-terminal of a peptide (Boxem et al, 2008). The SH3 
domains recognize proline-rich peptides. Notably, there are over one hundred genes 
encoding SH3 domains in the human genome, making them attractive targets to study 
domain-peptide interactions (Kaneko et al, 2008). To summarize, PPI modules are 
building blocks in a PPI network, and understanding them is the key to unlock the PPI 
puzzle in cells. 
 
PPI interface 
The major difference between a domain-domain based PPI and a domain-peptide based 
PPI is the size of the interface, which is a key parameter to quantitatively describe a PPI. 
The PPI interface is defined by the change of the accessible surface area (ASA) of 
interacting partners before and after their binding. Specifically, if protein A and protein B 
form a complex, their interacting interface will be ASA(A) + ASA(B) - ASA(AB), that 
is, the difference between the sum of individual ASA of two proteins and the ASA of the 
protein complex (Janin et al, 2008). PPI interfaces range from 550 to 4900 Å2, averaging 
800 Å2, and cover 6-30% of the monomer surface area (Archakov et al, 2003). The amino 
acid composition at different PPI interfaces can vary significantly, but arginine, histidine, 
asparagine, tryptophan, tyrosine, serine and hydrophobic amino acid residues are mostly 
observed (Veselovsky et al, 2002). Comparing large numbers of PPIs suggests that 
homocomplex interfaces are more hydrophobic than heterocomplex interfaces, and the 
hydrophobicity of a PPI interface is somewhere between that of protein interior 





interfaces of short-lived protein complexes are similar to the active sites of enzymes, 
while the interfaces of stable protein complexes resemble protein cores (Archakov et al, 
2003). An important way to describe the PPI interface is the "hotspot" theory. This theory 
states that at PPI binding interface most of binding energy just comes from a few key 
residues, which are surrounded by less important interactions from supportive residues 
(Clackson & Wells, 1995). Further analysis showes that these supportive residues may 
occlude solvent from hotspot residues (Bogan & Thorn, 1998).  
 
Non-covalent factors in PPI events 
The binding energy that drives the association of protein monomers is critical for PPIs. 
Many factors play roles in a biochemical reaction in terms of binding energy, but it is 
non-covalent factors that really matter for a PPI event, which, in a large way, may 
account for the dynamic and adaptive nature of life.  
 
Hydrophobic interaction is one of the most important binding energy contributors for 
PPIs. It is formed through the concentration of non-polar groups in aqueous solution. The 
hydrophobic effect in a PPI interface tends to exist as a region called "patch", the number 
of which varies from 1 to 15 at an interface. Each hydrophobic patch may cover 200–400 
Å2 area and can reach up to 3000 Å2 (Lijnzaad & Argos, 1997). The hydrophobic effect is 
more often observed in stable complexes than non-obligate interactions because of the 
more dynamic nature of the latter in water solution (Jones & Thornton, 1996).  
 





by the attraction of an electronegative atom (Acceptor) to the hydrogen atom covalently 
attached to another electronegative atom (Donor). On average, there is one hydrogen 
bond for each 100–200 Å2 area at a PPI interface, totally about 10 hydrogen bonds for the 
whole interface(Veselovsky et al, 2002). Oxygen–nitrogen based hydrogen bonds are 
more prevalent than others given the polar group composition of protein surface. Amino 
acids side chains form about 76% of hydrogen bonds at the PPI interface (Xu et al, 1997).  
It is noteworthy that water molecules play a significant role at PPI interface in terms of 
hydrogen bond formation. Because a water molecule can have more than one hydrogen 
bond by interacting with an amino acid residue and another water molecule at the same 
time, they help form a network of hydrogen bonds at PPI interfaces (Xu et al, 1997).  
 
The third important binding energy contributor for PPIs is the electrostatics. This is the 
attraction between two opposite charges. Consistent with the hydrophilic nature of 
protein surface, the average charge density at a protein surface is about 1.4 charged 
groups per 100 Å2, totaling up to 12 charges per PPI interface (Barlow & Thornton, 
1986). In contrast to the hydrogen bond formed only within the range of a dipole-dipole 
interaction, electrostatic attraction can mediate long-distance interaction between charged 
groups, which is very important for long-range protein associations (Janin et al, 2008).  
 
Steric complementarity is another factor that can affect the association of two interacting 
proteins in terms of binding energy. Protein surface can be decomposed into "knobs", 
"holes" and "flats", which form the basis of the space complementarity at a PPI interface. 





statistic analysis, dimeric proteins have the most complementary shape, and antibody-
protein interface shows the least complementarity, while protease-inhibitor complex 
displays moderate complementarity (Lawrence & Colman, 1993). Some PPI events may 
induce the conformation change of one or two interacting partners, which can 
significantly change the steric complementarity at the PPI interface.  
 
The last binding energy contributor for PPIs is the van der Waals interaction, which is 
quite weak compared to other factors, but it may become important in some weak PPI 
events. 
 
PPI kinetics and thermodynamics 
Quantitative analysis of PPI events is very important, and kinetics and thermodynamics 
are two critical aspects to characterize PPIs in this way. As mentioned before, PPI 
kinetics and thermodynamics are connected by one important parameter: the 
disassociation constant Kd, which is used to define the PPI affinity and can be determined 
by the ratio of the disassociation rate constant koff and the association rate constant kon 
(Kd =koff/kon). In a simple one-step binding model between a receptor (R) and a ligand (L) 
to form RL, the Kd is equal to the concentration of R when half of L forms complex RL at 
equilibrium. Many methods have been developed to determine the Kd., e.g. direct 
measurement of free ligand, indirect measurement of bound ligand, and competition 
methods with excessive free unlabeled ligand. Furthermore, some PPIs involve multiple 
proteins, which significantly complicate the experimental design. Therefore, it is very 






There are several critical points when measuring the Kd and stoichiometry of PPI events. 
Firstly, it is important to give enough time for the reaction to proceed for measuring Kd at 
equilibrium. Secondly, in order to accurately determine both binding stoichiometry and 
affinity in one experiment, protein concentration should be close to the binding constant, 
and an estimate range of 0.1 to 10 fold of Kd is ideal (Wilkinson, 2004). Thirdly, 
choosing a proper method to measure a specific PPI is critical. For different methods, 
equipment sensitivity at low concentration and protein aggregation at high concentration 
should be carefully weighed. For example, Nuclear magnetic resonance (NMR) may not 
be a good choice to measure a binding affinity tighter than micromolar because it needs 
protein at millimolar level to detect a signal(Wilkinson, 2004). However NMR is a 
perfect tool to measure low affinity PPIs. Another example is that gel filtration and 
electrophoresis cannot be used to measure PPIs with fast disassociation constants, since 
the equilibrium will be disturbed during the separation of proteins. 
 
 PPI thermodynamics is another critical part in understanding the nature of protein 
binding. The main thermodynamic parameters used to characterize PPIs include standard 
free energy change (△Go), Gibbs free energy (△G), enthalpy change (△H), and entropy 
change (△S). The relationship between these parameters can be established as the 








△G =△H -T△S 
Where R=gas constant, T=temperature, and Keq is the equilibrium constant. 
 
Based on these interrelationships, we can determine the standard free energy change of a 
PPI by measuring the Kd (1/Keq). For most PPIs, Kd falls into the range of 
10-4~10-14M, corresponding to a binding energy range of 6~19kcal/mol (Janin, 2000). 
The Gibbs free energy indicates the favorable direction of a process, and it is related to 
reaction temperature, changes of enthalpy and entropy. In PPI events, the enthalpy 
change is determined by hydrogen bond formation, electrostatic and van der Waals 
interactions, whereas the entropy change is decided by the freedom difference of 
elements in the system before and after binding, which can be further divided into 
conformation and association entropy change of protein partners and the entropy change 
of solvents (Archakov et al, 2003). Overall, if the system entropy change is the major 
contributor to the association of proteins, the PPI is entropy-driven. Otherwise, the 
enthalpy is the major contributor to the interaction (Veselovsky et al, 2002). However, in 
most cases the effects of enthalpy and entropy on Gibbs free energy are opposite to each 
other, leading to a smaller change to △G (Brady & Sharp, 1997). 
PPI research tools 
Protein interactome 
Although PPIs are complex and diverse, significant progress has been achieved in high-





the “interactome”, which is a map of entire PPI network in an organism (Parrish et al, 
2006). Two strategies have made great contribution to interactome studies: (i) detecting 
binary protein interaction with the Yeast Two-Hybrid (Y2H); and (ii) characterizing 
large-scale protein complex with Tandem Affinity Purification (TAP). Recently, several 
interactome maps based on binary interaction have been constructed, including maps 
from yeast (Fujimoto et al, 2001; Uetz et al, 2000), C. elegans (Burdine et al, 2004), 
Drosophila (Giot et al, 2003), and human (Rual et al, 2005; Stelzl et al, 2005). In addition 
to binary PPI screening, proteome-scale identification of protein complexes has also been 
carried out (Deane et al, 2002; Gavin et al, 2006; Gavin et al, 2002; Krogan et al, 2006), 
which can provide additional information about the PPI network organization. 
Interestingly, data obtained from these two strategies are largely complementary, which 
means neither of these strategies can cover the whole picture of an interactome.  
 
Undoubtedly, the elucidation of these interactome maps from different organisms takes 
great advantage of genome projects. However, we should never forget the role of the 
technical advancement on the discovery and identification of PPIs. Especially, Two 
techniques are noteworthy: Y2H and TAP. It is very interesting to find that, current 
interactome maps mentioned above were all constructed on these two platforms: Y2H 
system for binary interaction mapping and TAP-MS for proteome scale complex 
identification. 
Yeast Two-Hybrid (Y2H) 
Why is the Y2H system used so extensively for interactome mapping? To reveal the 





introduced in 1989 (Fields & Song, 1989) and has been applied for high-throughput 
screening since the 1990s (Parrish et al, 2006). This method is based on the modular 
structure of transcriptional factors, initially represented by Gal4, which has a DNA 
binding domain (BD) and a transcription activation domain (AD). In principle, the two 
proteins (bait and prey) to be tested for interaction are fused to BD or AD and expressed 
in yeast cells (eg. BD-bait and AD-prey). BD-bait can bind the upstream of a reporter 
gene. If the bait and the prey interact, the AD-prey will be brought to a promoter, which 
controls the expression of the reporter gene. As a result, the interaction can be detected 
by measuring reporter activity (See Figure 1.1). The Y2H system has been improved in 
many aspects since it was introduced. For example, AD from VP16 of Herpes Virus, BD 
and AD from E. coli protein LexA and B42 can be utilized to replace Gal4 components 
(Brent & Finley, 1997). In addition, a variety of different reporter genes and promoters 
have been explored, such as Gal4-responsive promoters from GAL2, GAL1, SPAL10, 
UASGAL1, MEL1 genes and reporter genes ADE2, HIS3, LEU2 and URA3. More 
significantly, the basic design of the Y2H has been exploited to develop related methods, 
such as Yeast One-Hybrid system, Yeast Three-Hybrid system, Mammalian Two-Hybrid 
system, Bacterial Two-Hybrid system, and splitting ubiquitin system. In summary, the 
Y2H system inspired many technologies and has made great contribution to our 








Figure1. 1 The principle of the Yeast Two-hybrid (Y2H). 
The Y2H method is based on reporting yeast transcription activation to detect PPIs. The 
system includes two fusion proteins, bait (X) fused with Gal4 DB domain and prey (Y) 
fused with GAL4 AD domain, 5xUAS (upstream activating sequence in promoter), and a 
selection reporter (HIS3 or LacZ). Once X and Y interact, the system can activate survive 
or colorimetric selection system. See text for details. This figure is derived from 
reference (Fields & Song, 1989). 
 
 
Although the Y2H system is a milestone in the development of biological research tools, 
it is not flawless. One limitation is that it can generate large numbers of false negative 
and false positive results. False negative results mean the Y2H system fails to detect 
some interactions. There are several situations that can cause this result. Firstly, the Y2H 
is based on transcription activation, but some proteins cannot fully function in the nucleus 
of the yeast cells. For example, membrane proteins and other proteins that require special 
conditions like low pH do not perform well in the Y2H assay. In addition, some proteins 
may contain a strong signal peptide, which will direct the protein to other organelles 
instead of the nucleus. Secondly, in yeast cells some posttranslational modifications, such 
as glycosylation and phosphorylation, cannot be recreated as those in the host cells (Van 
Criekinge & Beyaert, 1999). Thirdly, observable transcription activation in yeast cells 
requires more than 24 hours, making it difficult to detect some unstable and transient 
interactions. Fourthly, some proteins are toxic in yeast cells or become toxic when over-





can inhibit the reporter gene expression, so the Y2H system cannot be used to study 
them.  
 
In addition to false negative results, the Y2H can also generate false positive results, 
meaning some interactions detected by the Y2H system never occur under physiological 
condition. Generally, the Y2H false positives can be divided into two groups: 
“biological” or “technical”. A biological false positive is observed when an interaction is 
detected by the Y2H system, but the bait and the prey do not actually encounter one 
another in a normal host organism: they may be expressed at different times, under 
different conditions, in different organs or cell types, or in the same cell but at different 
compartments. There is no way to eliminate these false positives in the Y2H system. 
Technical false positives are also called “experimental” false positive results because 
they are generated from the procedure of the Y2H. There are several reasons accounting 
for this type of false positive results. Firstly, auto-activation of transcription caused by 
DB-bait chimerical protein can be a major issue. Some AD-prey fusion proteins can 
generate promoter specific false positive results. Therefore, it is important to use several 
reporter systems with different combination of reports and promoters (Brent & Finley, 
1997; Vidalain et al, 2004). Secondly, over-expression of DB-bait and AD-prey fusion 
proteins may cause false positive results. Thirdly, several different AD-prey plasmids can 
be transformed into one yeast cell and are stably maintained during the process of Y2H, 
which increases the chance of misidentifying the real interaction partner (accounting for 






False negatives and false positives have imposed significant limitations on the Y2H 
system. It has been estimated that about 50% or more of the PPIs detected by the Y2H 
high-throughput screening were not reliable (Deane et al, 2002; Fields, 2005; Sprinzak et 
al, 2003; von Mering et al, 2002). However, this is only part of the story. Because false 
negative results are “invisible”, we do not know to what degree the Y2H system fails to 
work. These limitations were highlighted by the first two yeast interactome papers 
(Fujimoto et al, 2001; Uetz et al, 2000): only ~20% of the interactions identified in both 
high-throughput Y2H studies were the same. 
Tandem affinity purification and Mass spectrum (TAP-MS) 
TAP-MS is another approach for identifying PPIs. It combines two methods: protein 
isolation (TAP, tandem affinity purification) and identification (MS, mass spectrometry). 
TAP is an advancement based on the protein detection, labeling, and purification 
techniques such as Co-Immunoprecipitation (Co-IP) and Pull-down Assay. Compared to 
other methods, the TAP can more efficiently remove non-specifically associated proteins. 
In principle, the TAP method introduces two "tandem" affinity tags joined by a protease 
cleavage site into the N or C-terminal of the target gene (bait). After the fusion protein is 
expressed in native cells, two sequential purification steps are applied to enrich the 
protein complex and remove nonspecifically bound proteins (See Figure 1.2)(Huber, 
2003). Purified proteins are then separated by SDS-PAGE or Liquid Chromatography 
(LC) and identified by MS (Rigaut et al, 1999). It is noteworthy that during the 
purification steps, the protein complexes are maintained in mild wash condition, allowing 
isolation of active and functional protein complexes. In addition, nonspecifically 








Figure 1. 2 Tandem affinity purification (TAP) for protein complex enrichment. 
This method uses two sequential steps to purify protein partners associated to the bait 
protein. The bait protein is expressed in host cells with two tags: ProtA (IgG–binding unit 
of Protein A) and CBP (calmodulin-binding peptide) joined by a TEV protease site. Two-
step purification has two advantages: (i) they can remove much more contaminant than 
one step purification. (ii) the protein complex and the function can be preserved after two 









By using tandem purification, this method reconciles the requirements for maintaining 
protein complex and eliminating as much impurity as possible (Kocher & Superti-Furga, 
2007). Initially, Rigaut et al. tested several tags and found that a combination of ProtA 
(IgG–binding unit of Protein A) and CBP (calmodulin-binding peptide) tag jointed by a 
TEV protease recognition sequence could efficiently recover the protein complex at low 
concentration, so they coined the term “TAP (Tandem Affinity Purification)” (Rigaut et 
al, 1999). After a decade of development, this method has been successfully applied to 
many PPI studies (Danial et al, 2003; Khan et al, 2005; Ranish et al, 2004; Wang et al, 
2006). A recent improvement for this method is to insert the whole TAP tag into the 
target gene locus in the host genome through site-specific DNA recombination, which 
allows the expression of the tagged gene under the control of its native promoter (Gavin 
et al, 2006; Gavin et al, 2002). The TAP-MS method has numerous advantages over other 
PPI identification methods: (i), only one component of the complex needs to be labeled, 
which minimizes the interference to the formation of protein complex. (ii), the interaction 
can happen at any location inside the cell, eliminating problems caused by differential 
protein localizations. (iii), this method can identify multiple protein partners in one 
experiment, which not only increases the efficiency but also provides information on the 
organization of protein interaction network and greatly facilitates the construction of PPI 
map. (iv), both purification steps are conducted under mild wash conditions, which is 
critical for preserving protein complexes and removing nonspecifically associated 
proteins. (v), cutting-edge LC and MS instruments can be exploited to increase the 






However, the TAP-MS strategy still has some limitations when applied to high-
throughput PPI screening, which has been indicated by the dramatically different datasets 
obtained from two similar studies (Goll & Uetz, 2006). There are several reasons 
underlying these differences. (i), protein complexes involve non-covalent association of 
multiple proteins. If subjected to extensive wash during purification, some complexes 
may dissociate. (ii), Although current protocol uses two mild washing steps to remove 
nonspecifically associated proteins, it is not sufficient to remove all of them (Gavin et al, 
2006). (iii), this method can only be used to identify PPIs with an affinity higher than 
50nM (Piehler, 2005). (iv), it can provide a snapshot of the interactions but cannot reveal 
the dynamic nature of biological events. (v), in most applications, purified proteins were 
separated, stained and digested in SDS-PAGE, which may become the limiting factors for 
detecting low abundant PPIs, because protein in-gel digestion efficiency is quite low 
(~20%) (Kocher & Superti-Furga, 2007),.  
 
Additional methods for PPI research 
Although the Y2H and TAP-MS are widely used for PPI detection, many other methods 
are also available, such as Fluorescence Resonance Energy Transfer (FRET), 
Bioluminescence Resonance Energy Transfer (BRET), Protein-fragment 
Complementation Assay (PCA), Phage Display, Far Western, in vivo cross-linking, 
Nuclear magnetic resonance (NMR), Surface Plasma Resonance (SPR), Atomic Force 
Microscopy (AFM), Analytical Ultracentrifugation, protein arrays, single-molecule 
imaging and bioinformatic tools. These methods can meet different criteria for diverse 





For example, FRET is a widely used method to detect PPIs in cells. Its derivative, BRET, 
replaces the fluorescent donor with bioluminescent protein. So, the signal can be 
observed without using laser as an excitation light source, which significantly reduces the 
background compared with the FRET. Another modification of the FRET is the FLIM 
(Fluorescence Lifetime Imaging), which can measure the energy transfer efficiency, 
information that can be used to estimate the distance between two interacting proteins.  
Table 1. 1 Features and applications of different techniques for protein interaction 
analysis* 
 
*This table is copied from reference (Piehler, 2005) 
PPI tools of interest 
Crosslinking and Photoaffinity labeling 
Chemical crosslinking, a process of chemically joining two molecules by a covalent 
bond, is a conventional tool for PPI analysis (Burdine et al, 2004). This method has long 
been used in biochemical studies to investigate the association of proteins, DNA/RNA 
and small molecules. Important chemical crosslinkers for PPI research include the 
general crosslinker formaldehyde and some bi- or tri- function crosslinkers. 
 
Formaldehyde is known for fixing biological materials to keep their natural shape and 
position. For example, it has been used in Chromatin Immunoprecipitation (ChIP), 
Technique Application Identification Localization Affinity Kinetics Throughput
Membrane 
proteins Kd range
Yeast two-hybrid In vivo ++ ++ <50 M
Protein fragment complementation In vivo + + + <10 M
Tandem affinity chromatography In vitro ++ ++ <50 Nm
Protein arrays In vitro + + ++ <1 M
FRET/BRET General ++ + <10 M
Solid-phase detection In vitro ++ ++ + + pM– M
Single-molecule detection General ++ ++ ++ + nM– M






Figure1. 3 Mechanism of formaldehyde-based protein crosslinking. 
The reaction is divided into three steps: [1], the formation of mythylol adduct; [2], 
dehydration; [3], meththylene bridge to the Schiff-base. A tyrosine residue is used in step 
[3] as an example. See text for detainsl. This figure is copied from reference (Metz et al, 
2004). 
 
Fluorescence in situ hybridization (FISH) and vaccine inactivation. Although 
formaldehyde’s function is very clear, its chemical mechanism is very complicated. After 
decades of intensive investigation (Fraenkel-Conrat & Olcott, 1948; Metz et al, 2004), 
the mechanism has now started to be uncovered. When introduced into a biological 
system, formaldehyde works initially through the formation of methylol adducts on 
amine groups. Subsequently, these adducts can be partially dehydrated to give labile 
Schiff-base. Finally, a stable product is formed by crosslinking amino acid residues via 
methylene bridge to the Schiff-base (See Figure 1.3)(Metz et al, 2004). Before the 





characterization of protein complexes. In recent years, however, its application on PPI 
detection has focused on analysis of transient and low affinity interactions, because pull-
down or Co-Immunoprecipitation cannot purify loosely associated proteins without 
fixation (Guerrero et al, 2006; Schmitt-Ulms et al, 2004). Based on the mechanism of 
formaldehyde crosslinking, it is not surprising that highly heterogeneous crosslinking 
products can be generated if it is used for PPI studies. Actually, heterogeneous 
crosslinking has become the major hurdle for the detailed characterization of PPI with 
formaldehyde based crosslinking method, because large amounts of non-specific 
crosslink products can produce false positive results, making it difficult to identify true 
interactions. The situation can be further complicated for those proteins with heavy post-
translational modifications(Borch et al, 2005; Vasilescu et al, 2004).  
 
 
In addition to direct application of simple crosslinkers such as formaldehyde on PPI 
characterization, multiple functional crosslinkers have also been developed, of which the 
label transfer method is a very good example. Label transfer reagent was initially 
developed with heterobifunctional crosslinkers (e.g. a photo-activable moiety and an 
electrophile), that is, two crosslinkers joined by a cleavable linker like disulfide, azo or 
ester. When used for PPI detection, a heterobifunctional crosslinker is first tethered to a 
bait protein via the electrophile group at one end. Subsequently, the bait-crosslinker 
complex binds to prey protein, and ultraviolet light is used to trigger labeling the prey via 
the photo-activable moiety. Lastly, the cleavable linker is severed, realizing the transfer 
of the label to the prey protein(Fancy, 2000). In its early stage, label transfer strategy 





to report the signal (Koch et al, 1994; Schwartz, 1985).  However, after decades of 
improvement many report groups have been used to enhance this method for PPI 
detection, such as fluorescent compounds and biotin. More than that, the overall design of 
the label transfer has also evolved, and many new techniques have been applied to revive 
this conventional method for PPI research. Recently, a brand new label transfer design 
using biarsenical FlAsH reagent to label bait protein has drawn a great deal of attention 
(Souza, 2007). In this design, the biarsenical FlAsH was combined with biotin and 
DOPA(Griffin et al, 1998), which could be oxidized by sodium periodate to generate a 
reactive ortho-quinone to crosslink a protein nearby. In this way, FlAsH moiety could be 
site specifically installed to the bait protein through an engineered FlAsH receptor 
peptide (FRP, CCPGCC). Based on this design, non-specific loading of label transfer 
reagent to unrelated proteins could be avoided and the label transfer efficiency could be 
increased significantly. In the report, Liu et al demonstrated the method by using a model 
system of 26S proteasome complex(Liu et al, 2007).  
 
Although many crosslinking methods have been used for PPI study, non-specific and 
uncontrollable crosslinking makes it difficult to identify the targets of interest. To meet 
the sophisticated requirement for PPI characterization, photoaffinity labeling was 
developed, which features activating crosslinker by light as a remote control. 
Photoaffinity labeling was first introduced in 1962 (Singh et al, 1962), after so many 
years, the general principle still holds: upon light irradiation, the crosslink compound is 
activated and a covalent bond is formed to couple target molecules in the proximity (see 





this method is becoming even more useful (Jahn et al, 2004). Although recent years have 
seen the applications of many photophores for photoaffinity labeling, most of them are 
derivates of three compounds: nitrene generated from acryl azides, carbene generated 
from diazirines, and photoreactive carbonyl group generated from benzophenone 
(Hatanaka & Sadakane, 2002). Among these leading photophores, acryl azides and 
diazirines are not very stable in ambient light. Because they can quickly react with a 
water molecule, they are not very efficient in photoaffinity labeling. On the other hand, 
benzophenone is preferred to acryl azides and diazirines because it is more stable to 
ambient light and protic solvents (Dorman & Prestwich, 2000; Jahn et al, 2004). 
However, the activated intermediate of benzophenone can randomly insert into proximate 
C-C or C-H bonds, leading to a huge population of heterogeneous crosslinked species 
that are difficult to characterize. Above all, current photoaffinity labeling systems are 
more or less defective. To address the challenges from PPI characterization, we need 
more powerful photoaffinity labeling tools that are more stable, controllable, and specific, 
generating more predictable result. 
 
 
Figure 1. 4 General principle of the Photoaffinity labeling method. 
The system contains the prey protein and the bait protein loaded with a photo-sensitive 
crosslinker. Upon light irradiation, the crosslinker can be activated and label the prey 
protein. Consequently, the prey protein can be enriched and identified. This figure is 





β-lactamase based PCA 
PCA is another interesting method for PPI characterization. It is based on the similar 
strategy to the Y2H. In the PCA system, a gene encoding an enzyme is firstly split into 
two fragments (for example, N and C terminal) and fused with a bait gene and a prey 
gene respectively. These fusion genes are then expressed in target cells to generate fusion 
proteins. If the bait and prey interact to form a complex, the two fragments of the enzyme 
will be brought into proximity. They will refold and become an active enzyme. 
Subsequently, by detecting the enzyme activity the interaction between the bait and the 
prey can be reported (See Figure 1.5) (Michnick, 2001). The difference between the PCA 
and the Y2H is in the reporter system. For the PCA, reporter itself is split; For the Y2H, a 
reporter system has to be introduced. Besides, the PCA allows the detection of PPI in its 
native compartment and original cells. However, in the Y2H, the interaction can only be 
detected in the nucleus of yeast cells. For the PCA system, two critical points must be 
noted. Firstly, PCA fragments should not refold spontaneously, otherwise, the system 
simply will not work (Michnick, 2001). Secondly, PCA is a switch-like system and it is 
an all-or-none process (See Figure 1.5c). In other words, the facilitated folding state of 
PCA fragments should be favored over any other intermediate forms if they are brought 
together (Michnick et al, 2007). Experimental results have shown that, in a PCA system, 
the fraction of refolded enzyme increases cooperatively as the ratio between the two 
fragments increases, resulting in a high dynamic range of reporter activity over a narrow 
range of protein ratio (See Figure 1.5c)(Galarneau et al, 2002; Michnick et al, 2000). 
Currently, there are several PCA systems available based on different reporters, such as 





α and ω domain mutations), β-lactamase, Gaussia Luciferase and GFP (Michnick et al, 
2007). Notably, PCA systems based on the complementation of fluorescent proteins are 
also called BiFC (Bimolecular Fluorescence Complementation). Because fluorescent 
protein based BiFC systems are not reversible, they have both advantages (for example, 
detecting low and transient interaction) and disadvantages (unable to show protein 




Figure 1. 5 Principle of the PCA. 
This method is based on splitting protein reporter to detect PPIs. It was found that the 
refolding of reporter fragments (green protein) in a PCA facilitated by the interaction 
between the bait and prey (red and blue ball) in (b) has no difference from the natural 
process of protein refolding showed in (a). Moreover, it is demonstrated that PCA is an 
all-or-non process and determined only on the stoichiometry ratio of the two fusion 







Among reporters used in the PCA system, β-lactamase (EC 3.5.2.6) is a very interesting 
one. β-Lactamase belongs to a group of enzymes that have evolved from penicillin-
binding proteins (PBPs)(Davies et al, 2001). These enzymes can hydrolyze the β-lactam 
ring in penicillin antibiotics. Of all β-Lactamases, TEM-1 is very unique and has 
numerous merits, which make it a good choice for the PCA system. Firstly, TEM-1 β-
lactamase is very efficient at hydrolyzing penicillin and cephalosporin, with rates close to 
the diffusion limit (108~109M-1 sec-1) (Christensen et al, 1990; Minasov et al, 2002). 
Secondly, it is a small and monomeric enzyme, with a molecular weight of 29 KD. 
Thirdly, its structure has been well characterized. Fourthly, it is not toxic to mammalian 
cells, and there is no ortholog in eukaryotic organisms (Galarneau et al, 2002). Fifthly, 
many TEM-1 substrates have been developed for different applications. For example, 
Nitrocefin can be used for in vitro colorimetric assay to measure TEM-1 activity 
(Galarneau et al, 2002). Cell permeable fluorescent substrate CCF2/AM can be used for 
in vivo imaging (Zlokarnik et al, 1998). At the same time, Penicillin can be easily 
modified to make substrates with new properties, for example, biotin-penicillin and 
fluorescein-penicillin. Lastly, the catalytic mechanism of TEM-1 β-lactamase has long 
been unveiled (Figure 1.6). β-lactamase is a serine-based hydrolase and Ser70 is at the 
activity center. During the reaction, the enzyme and substrate form an acyl-enzyme 
intermediate through Ser70 (Dalbadie-McFarland et al, 1982; Fisher et al, 1980). 
Notably, β-lactamase E166N mutation can trap the substrate penicillin to the enzyme by 
stabilizing the acyl-enzyme intermediate (Adachi et al, 1991; Minasov et al, 2002). 











Figure 1. 6 Catalytic mechanism of TEM-1 β-lactamase. 
TEM-1 β-lactamase is a serine-based hydrolase and works through two reaction steps: 
acylation and deacylation. Once the enzyme forms a complex with the substrate, they 
become a tetrahedral intermediate through Serine 70 residue, followed by the breakage of 
β-lactam ring and the formation of acyl-enzyme intermediate. In the presence of a water 
molecule activated by Glutamic acid residue at position 166, the acyl-enzyme 
intermediate is disrupted and the bond between the enzyme and substrate is broken. 
Subsequently, the reaction goes through deacylation and the enzyme is recycled for next 











TEM-1 β-lactamase based PCA was developed by two groups at almost the same time 
(Galarneau et al, 2002; Wehrman et al, 2002). Each provided us a unique angle to 
understand this method. Wehrman et al. split the TEM-1 into two fragments: α197 
(amino acid 25~197) and ω198 (amino acid 198~288). To test the idea of PCA, they 
fused these two fragments to several pairs of interacting proteins, including cJun and 
cFos, CD40ED and BW10-1, FKBP12 and FRB (with Rapamycin). They demonstrated 
that with different interacting pairs, TEM-1 β-lactamase based PCA could work in both 
E. coli and mammalian cells. They also showed that this method could be used to detect 
membrane and transient PPIs. Remarkably, they found that the signal-to-noise ratio of the 
method could increase by as many as 1,000,000 folds by introducing the tri-peptide NGR 
into the joint of α197-cJun, which probably works by stabilizing the α197 fragment and 
consequently the refolded β-lactamase (Wehrman et al, 2002). Similarly, Galarneau et al. 
dissected TEM-1 β-lactamase between Gly196 and Leu198 based on the structure. They 
also tested this splitting strategy with several known PPIs, including homodimerization of 
GCN4 leucine zipper domain (ZIP), heterodimerization of Bad and truncated Bcl2T, 
homodimerization of Smad3, and interaction between PKB and its substrate Bad. During 
their development, they introduced M182T mutation in TEM-1 β-lactamase to increase 
TEM-1 enzyme activity. Moreover, they made use of the interaction between FKBP and 
FRB triggered by rapamycin to titrate the refolding kinetics of the split fragments. 
Overall, these two pioneering studies introduced TEM-1 β-lactamase PCA to PPI 
research community. After that, several follow-up investigations were carried out(Schnee 





PPI studies(Jun & Wickner, 2007; Lee et al, 2007; Lee et al, 2004; Park et al, 2007), 
making it an ideal candidate for further development. 
 
Questions and aims 
Even though technologies for PPI detection are fast evolving, the demand for more robust 
PPI study tools is also surging. Because current technologies cannot solve many 
problems, we need new tools for PPI study. However, many challenges need to be 
addressed for the development of a new PPI characterization tool. For example, Can it be 
used in vivo? Can it detect low affinity and transient interactions? Is it effective for low 
abundant proteins? Does it work for membrane proteins? Is it repeatable? Can it be easily 
scaled up for high-throughput application? To meet these practical requirements, we need 
to reexamine our current tools and integrate the power of different methods.  
 
Based on previous discussion, we concluded that both PCA and crosslink methods could 
be adapted for many challenging applications. They were thus chosen for further 
development. The overall goal throughout this research was to label interacting target 
proteins with a strong covalent bond. A possible way to achieve this goal is to combine 
the advantages in both top-down and bottom-up strategies. Specifically, effort will be 
paid to integrate PCA, protein labeling and crosslinking, pull-down and MS to hit the 





Chapter two,  




Protein photoaffinity labeling is a useful method for PPI analysis. However, conventional 
photoaffinity labeling agents, such as carbene, nitrene and benzophenone are impaired by 
their limited photo-stability, low labeling efficiency and poor reaction specificity. In this 
study, a new photoaffinity labeling agent was developed through the photo-generation of 
a reactive intermediate, para-quinone methide (pQM). Photochemical analysis showed 
that two related photocaging groups, PC-1 and PC-2 could be effectively removed from 
the pQM precursor by UV light at 365nm. PC-2 could even be removed by visible light at 
400nm. Reactivity characterization of the agent revealed that several amino acid residues 
could be labeled once they were in close proximity to the pQM. Protein labeling 
experiment, using a PPI pair catPTP1Bm and EGFR peptide carrying the pQM precursor 
(pep-1), found that the target protein could be specifically labeled at a concentration as 
low as 0.1nM in the presence of a thiol scavenger group. Moreover, MS mapping 
experiment indicated that two peptides from the target protein were labeled by the 
photoaffinity functional group, which further confirmed the crosslink specificity of this 
method. In addition, the MS experiment also showed that this method could greatly 
simplify the procedure of identifying crosslinked sites. In summary, it was demonstrated 








Photoaffinity labeling is a useful tool for the characterization of protein-ligand 
recognition or protein-protein association, especially for those with low affinity or short 
lifetime. This method features labeling the target protein with a covalent bond and can be 
divided into several stages. It starts with the interaction between the target protein and the 
bait probe. A light signal is then used to convert the crosslinker precursor to a short-lived 
but highly reactive intermediate, followed by the formation of a covalent bond bridging 
the bait probe and the target protein. In the end, the labeled target protein can be isolated 
and characterized by LC-MS/MS (PlaW, 1997). As we can see from this procedure, a 
photoaffinity labeling system contains these important components: a light harvesting 
structure, a cross-linker precursor, a bait probe, and a labeling marker.  
 
Photocaging groups 
The light harvesting structure plays a critical role in the photoaffinity labeling strategy. 
For traditional radical-based photo-crosslinkers, the light harvesting moiety and the 
crosslinker precursor are integrated into one group. However, it has been found that some 
specialized light harvesting groups, called photocaging groups, can be more efficiently 
removed by light at certain wavelengths. If these groups are applied to protect a chemical 
crosslinker, very likely, the photoaffinity labeling system will be more efficient. The 
desired properties for a photocaging group include chemical stability before 
photoactivation and rapid photolysis rate at a longer wavelength (Chowdhry & 





processes, nitrobenzyl derivates have been shown to be efficient, reliable and versatile in 
many biological applications (Young & Deiters, 2007). As an example, photocaged 
amino acid 4,5-dimethoxy-2-nitrobenzylserine (DMNB-Ser), an unnatural amino acid, 
has been genetically introduced into yeast cells to control protein phosphorylation 
(Lemke et al, 2007). In our study, nitrobenzyl derivates were chosen as our photocaging 
candidates (See Figure 2.1) 
 
 
Figure 2. 1 Photocaging strategy and some caging groups. 
The concept of photocaging (upper) and typical photocaging groups (lower). Substituent 
on 1: R1 = H, R2 = H: o-nitrobenzyl (ONB); R1 = OCH3, R2 = H: 4,5-dimethoxy-2-
nitrobenzyl (DMNB); R1 =OCH3, R2 = CH3; (4,5-dimethoxy-2-nitrophenyl)ethyl 
(DMNPE). 2:6-bromo-7-hydroxycoumarin-4-ylmethyl (BHC). This figure is copied from 
reference (Young and Deiters, 2007). 
 
Chemical intermediate pQM as a crosslinker 
The most critical component in a photoaffinity labeling system is the crosslinker. As 
mentioned before, conventional photoaffinity crosslinkers have limitations in their 
reactivity, stability and efficiency. It might therefore be necessary to introduce new 
crosslinkers into the photoaffinity labeling toolkit to broaden the application of this 





crosslinkers for the characterization of protein interactions. For example, they have been 
found to be efficient protein crosslinkers when activated by enzymatic reactions, such as 
dephosphorylation (Deane et al, 2002; Komatsu et al, 2006).  
 
 
Figure 2. 2 Simple examples of quinone and quinone methide. 
Quinones have two carbonyl oxygen groups in the six-member ring with two isoforms: 
ortho-quinone or para-quinone. Quinone methides have a carbonyl oxygen group and a 
methylene group also with ortho- and para-isoforms. 
 
 
Quinone methides have a close relationship to quinones, which are a class of chemicals 
naturally found in organic world and widely used in chemical synthesis (see Figure 2.2). 
Quinone methides are different from quinones in that a methylene group and a carbonyl 
group occupy two positions on a cyclohexadiene ring. Based on the position of these two 
functional groups, the quinone methides have two isoforms: ortho- and para- quinone 
methides (Figure 2.2). Because quinone methides have two different functional groups, 
they are highly polarized and more active than their parental quinones. However, they are 
not as active as quinonedimethane, in which both carbonyl groups in quinone are 
replaced by methylene (Rokita, 2009a). At the same time, quinone methides have a 
dipolar nature and contain both cationic and anionic centers. They can react with both 








nucleophiles and electrophiles to generate an aromatic phenol ring, which is a driving 
force for their reactivity (Chiang et al, 2000). The extensive exploration of quinone 
methide chemistry has established a solid foundation for the application of these 
compounds, and thus they were used as the crosslinker in our photoaffinity labeling 
method.  
 
A new design of photoaffinity labeling method 
In order to develop a new photoaffinity labeling method for characterizing protein-
protein or protein-peptide recognition, we planned to use a new combination of different 
components in the photoaffinity labeling system, which featured following elements: 
Firstly, we adapted photocaging group nitrobenzyl derivates to protect the crosslinker. 
Secondly, we chose para-quinone methide as the crosslinker for a more specific labeling. 
Thirdly, we used a PPI pair between the PTP1B trapping mutant (catPTP1Bm, core 
domain with C215S mutation) and its binding peptide from EGFR (988–998) to 
demonstrate the advantage of the new system. Lastly, we added a biotin to the peptide 
and joined them to the crosslinker by an acid-labile linker. Over all, our aim was to 
develop a system that would follow the general principle of photoaffinity labeling 
strategy but be more sensitive, stable and specific.  
 
In summary, a new photoaffinity labeling probe was designed, which had nitrobenzyl 
derivate as photocaging group, pQM as crosslinker, an acid cleavable biotin tag, and a 
bait peptide to target prey protein catPTP1Bm. Based on the design, UV light would be 





crosslinker pQM. This reactive intermediate would then be attacked by the nucleophile 
group on catPTP1B surface to form a covalent bond. Next, the crosslinked target protein 
would be enriched and analyzed by MS.  
 
Materials and methods 
Chemicals and compounds 
All chemicals, solvents and reagents used in this research are ACS Reagent Grade or 
Molecular Biology Grade, and they were purchased from Sigma, Fisher Scientific, EMD 
Merk or Acros Organic. Besides, some compounds were synthesized by Dr. Dexing Zeng 
in Li lab, and they were examined by MS and NMR to confirm their structure and purity. 
These compounds included: PC-1, PC-2, the template system to test amino acid activity 
to pQM and pep-1 used in protein crosslinking experiment. For detailed information 
about chemical synthesis of these compounds, please check reference (Jiang et al, 2009) 
Determining the absorbance and photolysis efficiency of PC-1 and PC-2  
Compound PC-1 and PC-2 were dissolved in 50mM HEPES buffer pH 7.2 with 30% 
acetonitrile. The absorbance was scanned with FluoroMax-2 Spectrofluorometer (ISA, 
Inc.). For photolysis experiment, 100µL solution was exposed to UV light (365 nm, 
Intensity = 4 mW/cm2). Repeat experiments were conducted for variable durations, and 
product from each experiment was then analyzed by HPLC. The percentage of remaining 







Measuring the reactivity between quinone methide and amino acids 
A serial of nine compounds with nine selected amino acids in the one template were used 
for this experiment. See reference for synthesis and structure information (Jiang et al, 
2009). Each compound was dissolved in a freshly prepared mixture of 50mM HEPES 
buffer (pH 7.2) and 50% acetonitrile to 100 µM, and then tested with two conditions. 
Under condition A, the compound was deprotected with UV light (365 nM, 4 mW/cm2, 
the UV intensity was determined by TraceableTM UV Light Meter, Fisher Scientific Inc.) 
for 5 min. 10 mM β-mercaptoethanol (βMe) was then added to stop the reaction. The 
final products were analyzed by HPLC with a detector at 473 nm. Under condition B, the 
compound was deprotected with UV light (365 nM, 4 mW/cm2) for 5 min in the presence 
of 1 mM βMe. The final products were also analyzed by HPLC (gradient: from 10% 
acetonitrile in water to 90% acetonitrile in water in 30 min). All sample peaks were 
subsequently collected from HPLC and analyzed by MS. 
Gene mutation and plasmid construction 
CDS of PTP1B catalytic domain (amino acid 1~321) was amplified from a plasmid 
containing human PTP1B gene (Invitrogen, clone ID 4338750) using the high fidelity 
amplification kit (Bio-Rad, Cat. No.172-5301) with primers OSL038 and OSL041. This 
PCR product contained a SacII site at the N-terminal and a stop codon followed by a 
BamHI site at the C-terminal. Complementary primers OSL042 and OSL043 were then 
used to introduce the mutation C215S in the PTP1B catalytic domain. The mutation 
procedure included two rounds of PCR. OSL038 and OSL043 were used to amplify the 
N-terminal of the catalytic domain and generate fragment-1. OSL042 and OSL041 were 





fragment-1 and -2 were purified with agrose gel, they were combined as the template for 
another round of PCR with primers OSL038 and OSL041. The PCR product was purified 
by Qiaquick column (Qiagen), digested with SacII and BamHI (NEB). The expression 
vector was derived from pET11c(+) (Novagen). Briefly, a DNA fragment containing His-
tag followed by a synthetic human ubiquitin gene and a SacII restriction site was 
amplified and cloned into the pET11c through NdeI and BamHI sites to replace the T7 
tag in the vector. In the end, the PTP1B catalytic domain with C215S was cloned into the 
expression vector through SacII and BamHI sites. 
 
Protein expression and purification 
catPTP1Bm expression plasmid was transformed into BL21 (DE3) cells (Stratagene) and 
selected on a LB plate containing 50 µg/mL ampicillin. After growing overnight at 37°C, 
a single colony was picked and inoculated into 5 ml LB with 100 µg/ml ampicillin as 
seed culture. After growing overnight at 37°C, 1 ml seed culture was inoculated into 100 
ml fresh LB with 100 µg/mL ampicillin, and grew at 37°C until OD600 reached ~0.6. 
IPTG was then added to induce the gene expression at a concentration of 1 mM. After 
growing 3 hours at 37°C, cells were cooled to 4°C and collected through a centrifugation 
at 10, 000 g. 
 
Cells from 100 ml culture were lysed for 15 min at room temperature by adding 2 ml 
Bugbuster plus 2 µL of Benzonase (Novagen). Insoluble cell debris was removed by 
centrifugation at 45 000 g for 30 min at 4°C. The supernatant was mixed with 10 ml 





(bed volume) pre-equilibrated Ni-column (Bio-Rad), and allowed to bind with the 
column at 4°C for 1 hr on a rotator/shaker. The column was washed extensively with 10 
ml buffer A, and 50 ml buffer A containing 30 mM imidazole, then eluted with 10 ml 
buffer A with 400 mM imidazole. Ten fractions were collected and 15 µL of each 
fraction was loaded onto SDS-PAGE to determine which fraction contained target 
protein. Protein concentration was determined by the Bradford assay following the 
manufacturer’s instruction (Sigma).  
 
Photocrosslinking with different DTT concentrations 
 Purified catPTP1Bm and cell lysate prepared from strain BL21 DE3 were first dialyzed 
against deprotection buffer (50 mM HEPES, pH 7.2, NaCl 150 mM) overnight at 4 °C, 
and their concentrations were determined by the Bradford assay (Sigma). For 
crosslinking reaction, different concentration of DTT (0 nM, 100 nM, 1 µM, 10 µM, 0.1 
mM, 0.5 mM, 1 mM, 5 mM) and 100 µg bacterial cell lysate were mixed in 100 µL 
solution with 10 nM catPTP1Bm and 1 µM pep-1. The deprotection was carried out with 
FluoroMax2 instrument for 5 min at 365nm (4 mW/cm2). Samples were then 
concentrated with SpeedVac and loaded onto a SDS-PAGE gel, followed by western 
blotting to detect crosslinked protein. After the membrane was blocked overnight in 5% 
milk in PBS with 0.05% Tween-20, strepavidin-HRP conjugate was added to the solution 
and incubated for 1 h at room temperature. The membrane was washed with TBS (10 
mL, 20 mM Tris buffer, pH 8.0, 150 mM NaCl) for 3 times, 5 min each time. 
Subsequently, HRP substrate was added, and the chemiluminescence signal was recorded 






Photocrosslinking with pep-1 under different concentration of catPTP1Bm 
The procedure was the same as that described above, but DTT concentration was kept at 
100 µM and catPTP1Bm concentration changed (0.1 nM, 1nM, 5 nM, 10 nM, 25 nM, 
100 nM, 1 µM) in each reaction.  
 
Identification of crosslinked peptides with MS 
After photocrosslinking reaction between catPTP1Bm and pep-1 peptide, 6 M urea and 
10 mM DTT were added to denature and reduce the protein, then 55 mM 
bromoacetamide was added to the mixture and incubated at 37 °C for 2 hours in 
darkness. Excess DTT was added again to quench the unreacted bromoacetamide. Next, 
the sample was dialyzed overnight using 10KD MWCO dialysis cassette (Pierce). This 
step removed both small molecules and excess pep-1 in the sample. The sample was then 
mixed with 4 volumes of pre-chilled acetone, incubated at -20 °C for 1 h, and precipitated 
by a centrifuge at 45, 000 g for 20 min. The pellet was dissolved in 200 µl 6 M urea, 100 
mM NH4HCO3, and the solution was diluted with 1.8 ml 100 mM NH4HCO3. 10 µg of 
trypsin (Sigma, proteome grade) was added to digest the protein for 20 h at 37 °C. After 
digestion, trypsin was removed by incubating with immobilized trypsin inhibitor (Sigma). 
Then, the biotinylated peptide was enriched with monomeric avidin agrose by following 
manufacture’s instruction (Pierce). The purified peptides were treated with acid cocktail 
(88% TFA, 5% H2O, 5% phenol, 2% Triisopropylsilane), dried with lyophilizer, mixed 
with MS matrix (10mg/ml α-cyano-4-hydroxycinnamic acid in 50% acetonitrile, 0.1% 







Characterizing two photocaging groups derived from nitrobenzyl moieties 
Photocaging group in our photoaffinity labeling design is critical because it can affect 
photolysis efficiency, crosslinking activity and probe stability. We decided to use 
nitrobenzyl derivates as our photocaging groups, and two pQM precursors PC-1 and PC-
2 with two slightly different nitrobenzyl species were synthesized (See Figure 2.3).  
 
Figure 2. 3 Photocaging groups PC-1 and PC-2. 
Two photocaging groups PC-1 and PC-2 were derived from nitrobenzyl group. They 
were installed to protect pQM. During application, they could be deprotected to label the 
nucleophile groups in a protein. 
 
 
In order to carry out photoaffinity labeling, a light source is used to deliver energy to the 
probe. Depending on their different photochemical properties, photocaging groups can be 
photolysed by light with different wavelength. Currently, most photoaffinity labeling 
studies use high energy UV or Flash Laser Photolysis (FLP) to activate crosslinking. The 
major problem associated with these methods is that high-level energy during photolysis 
may cause significant damage to biological molecules. As an initial step of our study, we 
characterized our photocaging groups and compared their photochemical properties, so 





scan for both PC-1 and PC-2 was firstly conducted. Our data showed that compound PC-
2 had an absorbance peak at 348nm, and the absorbance extended to over 400nm. In the 
mean time, compound PC-1 did not show significant absorbance at longer wavelength. 
Instead, it showed an absorbance peak at 264nm (Figure 2.4A). Next, we deprotected PC-
1 and PC-2 with 365nm UV light (4mW/cm2), PC-2 with 400nm UV light (4mW/cm2) 
for variable durations. The products from these reactions were then analyzed by HPLC to 
measure the amount of materials left after deprotection. After the experiment, the ratio of 
PC-1 and PC-2 leftovers to starting materials against different time points was plotted 
(Figure 2.4B). In order to compare the photo-deprotection efficiency of these compounds, 
the time required to deprotect 50% of PC-1 or PC-2 was defined as T50%. Our result 
showed that with 365nm, 4mW/cm2 UV light, the T50% of PC-1 and PC-2 was 1.75min 
and 0.80min respectively, and PC-2 had a T50% of 4min with 400nm light. These data 
demonstrated that both PC-1 and PC-2 could be deprotected by UV light and our design 
of photocaging groups PC-1 and PC-2 was successful. Moreover, it was also shown that 
PC-2 was better than PC-1 in terms of photolysis efficiency at longer wavelength. Based 
on these data, it was concluded that PC-2 was an ideal photocaging group, and it would 







Figure 2. 4 Photochemical characterization of PC-1 and PC-2 caged pQM.  
A, absorbance scan for pQM precursor caged by PC-1 and PC-2. B, photolsyis 
experiment to test deprotection efficiency for both compounds. For photolysis, the 
compounds were reconstituted to 500µM in HEPES buffer, pH 7.2 with 30% acetonitrile. 
UV light (4 mW/cm2) was used to deprotect the material followed by HPLC analysis. The 
ratio of residue compound to starting material was plotted against time and got the graph. 
This result showed that the photolysis of PC-2 was more efficient than that of PC-1, 
because it could even be deprotected by visible light with the same intensity. 
 
Investigating the reactivity between pQM and amino acids 
To apply pQM-based photoaffinity labeling strategy on the characterization of protein-
peptide or protein-protein interaction, we had to firstly know which amino acid could be 
crosslinked by the pQM. Previously, the reactivity of QM species to biomolecules, such 
as DNA, peptide and glutathione, has been intensively investigated. It was found that 
amines and sulfide in amino acids and glutathione could be alkylated by QM through 
Michael addition. However, because most of the investigations about amino acids 
focused on the reactivity between QM and free amino acids, it was necessary to 
characterize the reaction between pQM and amino acid side chains in a protein. In a 
recently study, complementary PNA molecules (peptide nuclear acid) were used to bring 





found that α- and γ-amino of Lys, imidazole of His, and thiol of Cys could react with 
DOPA derived ortho-quinone (Liu et al, 2006). To advance our understanding on the 
pQM crosslinking mechanism, a template molecule was designed to bring the pQM 
precursor and an amino acid together for deprotection. We hoped this experiment would 
reveal the reactivity between pQM and various amino acids under a condition that 
mimicked protein crosslinking reaction (Figure 2.5A). 
 
The template system used in our study was composed of a crosslinker precursor with the 
photocaging group, an amino acid side chain, and a chromogenic dye Dabcyl, which had 
strong absorbance at 473 nm and would help us on HPLC analysis of reaction products 
(Figure 2.5A). For this template system, nine amino acids were selected to represent 20 
natural amino acids with different side chains: lysine, arginine, tyrosine, aspartic acid, 
asparagine, histidine, serine, methionine and tryptophan. Accordingly, nine compounds 
were synthesized, purified by HPLC and analyzed by MS. A final concentration of 100 
µM of each compound was used to run two experiments: procedure A and B. In 
procedure A, the sample was first irradiated with UV light, and βMe was then added to 
10mM to quench unreacted intermediate. In procedure B, the sample was irradiated with 
UV in the presence of 1mM βMe. After reaction, both samples were analyzed by HPLC  
(acetonitrile gradient: 10% to 90% in 30 min) and all product peaks were collected and 
analyzed by MS. Based on the design of procedure A and B (Figure 2.5B), the compound 
I could be deprotected by UV light to form compound II, which could generate an 
intramolecular crosslink product compound III if the amino acid side chain could react 





adduction product compound V if free thiol group was absent in the system. There were 
several reasons to add βMe in the procedure A and B. Firstly, compound II and III had 
the same molecular weight and were difficult to tell from each other simply by MS 
analysis. However, compound II was an active intermediate, in the presence of free thiol 
group, it could be quickly quenched and form thiol adduction compound IV. Besides, by 
adding βMe to both procedures, we could tell which amino acid side chain could out-
compete free thiol group for pQM to form intramolecular crosslink product, which is 
especially important when this method is used for the characterization of protein and 
peptide recognition in live cells, where free thiol concentration can be up to 10mM 

























Figure 2. 5 Amino acid deprotection and crosslinking assay. 
A, Generation of nine compound Is with different amino acid residues. For detailed 
synthesis procedure, please see reference (Jiang et al, 2009). Each compound I contains a 
pink dye Dabcyl, a PC-2 caged pQM precursor and an amino acid residue. The dye has 
an absorbance at 473nm and was used to facilitate HPLC analysis because there would be 
no appropriate chromophore in the compound otherwise. B, different reaction 
possibilities after the deprotection. Compound I was deprotected by UV at 365nm, and an 
unstable intermediate was firstly formed. Consequently, active pQM was generated 
through molecular rearrangement (II), followed by reaction with either the amino acid 
side chain or thiol scavenger or water to generate intromolecular crosslink (III) or thiol 








After reaction, HPLC and MS data were analyzed. It was found that all nine amino acids 
under investigation could be divided into three groups based on their reactivity toward 
pQM (see Figure 2.6 and Table 2.1). Group I amino acids were those actively crosslinked 
by pQM, including cysteine, histidine, lysine, aspartic acid and glutamic acid. Cysteine 
contains a thiol group, which is very reactive to pQM and was used as a quench group in 
this study. Histidine, aspartic acid and glutamic acid were also very reactive and could be 
crosslinked, even in the presence of thiol group (see Figure 2.6). Lysine is also reactive, 
but there was only a small fraction of intramolecular crosslinking in the presence of thiol 
group. Group II amino acids included tyrosine and tryptophan. These two amino acids 
could moderately react with pQM without thiol (see Figure 2.6 and Table 2.1). With thiol 
in the system, however, we didn’t see intramolecular crosslinked product (See Figure 2.6 
Tyr-B and Trp-B). Instead, thiol adduction product dominated the reaction. These 
observations meant although tyrosine and tryptophan could react with pQM, they could 
not out-compete free thiol group for the reaction. Group III amino acids included serine, 
methionine, arginine, asparine, glutamine and all other amino acids without a good 
























Figure 2. 6 Reactivity of different amino acids toward the pQM. 
Each compound I with a unique amino acid residue shown in Figure 2.5 was dissolved to 
get a 100 µM solution and tested with two conditions. Under condition A, deprotection 
was carried out with UV light (365 nm, 4 mW/cm2) for 5 min, then 10 mM βMe was added to 
stop the reaction. Under condition B, the same compound was deprotected with UV light (365 
nm, 4 mW/cm2) for 5 min in the presence of 1 mM βMe. The final products from both 
reactions were analyzed with HPLC and major peaks were collected and analyzed by MS. 
This figure shows the HPLC result, X-axis representing retention time, Y-axis representing 
signal intensity. For each reaction, the intramolecular adducts, βMe adducts, and water adducts 
are colored in red, blue, and green respectively. The unreacted starting material is shown in 
black. Numbers in parentheses are the m/z (mass to charge ratio) of the peak, and the 







Table 2. 1 Summary of amino acid deprotection assay  







Lys A YES YES NO NO 
Lys B YES YES YES NO 
His A YES YES NO NO 
His B YES YES YES NO 
Asp A YES YES YES NO 
I 
Asp B YES YES YES NO 
Trp A YES YES NO YES 
Trp B YES NO YES YES 
Tyr A YES YES NO YES 
II 
Tyr B YES NO YES NO 
Arg A YES NO YES YES 
Arg B YES NO YES NO 
Ser A YES NO YES YES 
Ser B YES NO YES NO 
Met A YES NO YES YES 
III 
Met A YES NO YES NO 
Note: Letter A or B behind each amino acid represent different reaction conditions, 
and A refers to the deprotection in the absence of thiol, but thiol was added to 
10mM to quench the rest pQM after the deprotection; B refers to the deprotection in 
the presence of 1mM thiol. In this summary, amino acids are categorized into three 





Our investigation on amino acids and pQM reactivity showed that many amino acids on a 
protein surface could be crosslinked by the pQM compound if they were brought into the 
proximity. Moreover, these data provided some guidelines for the characterization of 
pQM crosslinking site on a protein, which would be our next interest. 
 
Labeling catPTP1Bm with pQM based photoaffinity method 
To develop pQM based photoaffinity system for PPI study, we used a PPI model to 
demonstrate the method. In this interaction model, prey protein was the catalytic domain 
of protein tyrosine phosphotase 1B C215S trapping mutant (catPTP1Bm) (Flint et al, 
1997), and the bait was its binding peptide DADEpYLIPQQG from epidermal growth 
factor (EGF) receptor (988-998) (Milarski et al, 1993). The affinity between these two 
proteins is 395nM (Jia et al, 1995), which is moderate and makes this pair a good 
representative for different PPIs.  
 
For this experiment, the bait probe (pep-1) was synthesized (Jiang et al, 2009), which 
contained the PC-2 photocaging group, pQM precursor, an acid-labile linker, a biotin tag, 
and EGFR peptide with phosphorylated tyrosine at position 992 (See Figure 2.7A). At the 
same time, the prey protein catPTP1Bm was expressed in a modified pET11(c)+ vector 







Figure 2. 7 Preparation of pep-1 and catPTP1Bm for photoaffinity labeling. 
A, pep-1 containing EGFR peptide (988-998), affinity tag, acid labile linker and PC-2 
caged pQM precursor; B, the map of the plasmid constructed for expressing catPTP1Bm; 
C, purified protein catPTP1Bm. 
 
 
Next, 10nM catPTP1Bm and 1µM peptide probe (pep-1) were mixed in the presence of 
0.5mM DTT as scavenger at room temperature. The sample was irradiated by UV light 
for 5 min at 365nm (4 mW/cm2) and then separated with SDS-PAGE. After that, we did a 
western blotting experiment with streptavidin conjugated HRP to detect the protein 
product generated from the photoaffinity labeling. Our result showed that the target 
protein catPTP1Bm was successfully labeled (see Figure 2.8, left). Although this 
experiment was carried out with a purified protein, it demonstrated that the overall design 






Figure 2. 8 Photoaffinity labeling assay with purified protein. 
Photoaffinity labeling of target protein catPTP1Bm was done with pep-1 containing 
photocaged pQM precursor. Purified catPTP1Bm was mixed with the pep-1, and the 
deprotection was carried out in the presence of 0.5mM DTT. After deprotection, the 
sample was then resolved by SDS-PAGE followed by western blotting for the detection 
of biotin tag. Left, western blotting result; Right, the same membrane was aligned with 
the western image. 
 
pQM based photoaffinity labeling was specific and sensitive 
When we were developing this method, an interesting question was how it would perform 
in physiological condition. It has long been revealed that the physiological condition in a 
living cell is a reducing environment, which is maintained by the exchange between 
glutathione (GSH) and glutathione disulfide (GSSG). It has also been found that the 
physiological glutathione concentration varies from 0.1mM to 10mM (Bremer et al, 
1981). In our previous experiment, we found that thiol group had high reactivity toward 
our photoaffinity labeling reagent. However, some amino acids could compete with free 
thiol if they were close to the photoaffinity labeling moiety. In the mean time, free thiol 





concentration range of free thiol in physiological condition and its high reactivity toward 
our pQM based photoaffinity labeling reagent, it was necessary to investigate how our 
method would perform in physiological concentrations, that is, could free thiol in 
physiological condition be used as a scavenger for our photoaffinity labeling method?  
 
To address this issue, a DTT titration experiment was conducted. Specifically, a series of 
samples containing 10nM protein catPTP1Bm, 1µM peptide probe, 1µg/µl bacterial cell 
lysate and different concentration of DTT (from 0 to 5mM) were prepared. The purpose 
to add bacterial cell lysate in these samples was to test the photoaffinity labeling 
specificity in a complex environment. All samples except a control were irradiated by UV 
light under the same conditions as used before. After reaction, samples were separated 
with SDS-PAGE and blotted with strepavidin-HRP conjugate to detect labeled products. 
As a comparison, another SDS-PAGE loaded with the same set of samples was stained 
with Coomassie blue to show the total amount of proteins in each lane. In the end, it was 
found when DTT concentration was low, multiple protein bands were observed, which 
might be caused by non-specific labeling between the peptide probe and some proteins.  
Once DTT concentration was higher than 0.1mM, however, only a strong catPTP1Bm 
band and a faint unidentified protein band were still visible, indicating thiol at these 
levels could dramatically improve the specificity of our photoaffinity labeling reaction 
(see Figure 2.9). In order to quantify this result, we determined the specificity of our 
crosslinking result by measuring the main band intensity and the background signal level 
with ImageJ software. Our result showed that when DTT concentration was higher than 







Figure 2. 9 DTT titration assay for pQM based photoaffinity labeling. 
The purpose of this experiment was to test the effect of different thiol concentrations on 
the photoaffinity labeling efficiency and specificity. Purified catPTP1Bm with pep-1 was 
spiked in bacterial cell lysate and deprotected with UV light at different concentrations of 
DTT except the last sample lane, which was a control and not deprotected. After 
deprotection, the samples were resolved in two SDS-PAGE gels: one for coomassie blue 
stain (upper) and one for western blotting using HRP conjugated streptavidin (lower). In 
upper picture, we could see the cell lysate concentrations were the same for each lane, 
while in lower picture, western signal was getting more specific to the catPTP1Bm with 
the increase of scavenger concentration. The measurement of the mainband intensity, 
background signal intensity and their ratio is provided in Table 2.2. 
 
 Table 2. 2 Quantifying protein crosslinking specificity for the DTT titration assay* 
Lane TA MB BG MB/BG NTA NMB NBG NMB/NBG 
1 374708 156676 218032 0.72 243650 145013 98637 1.47 
2 387871 144065 243806 0.59 256813 132402 124411 1.06 
3 360958 144942 216016 0.67 229900 133279 96621 1.38 
4 352715 141819 210896 0.67 221657 130156 91501 1.42 
5 250545 103883 146662 0.71 119487 92220 27267 3.38 
6 277783 126207 151576 0.83 146725 114544 32181 3.56 
7 236558 104574 131984 0.79 105500 92911 12589 7.38 
8 170211 45214 124997 0.36 39153 33551 5602 5.99 





* The measurement was done by ImageJ, and the unit is “Gray value”. The red part of the 
form is normalized by lane 9. TA=Total; NTA = Normalized Total; MB= Main Band; 
NMB = Normalized Main Band; BG = Background; NBG = Normalized Background. 
 
concentration of glutathione varies from 0.1mM to 10 mM in living cells (Bremer et al, 
1981), which was similar to the range of thiol group in our DTT titration assay, we 
concluded that pQM based photoaffinity labeling would be highly specific even inside 
cells. 
 
Protein concentration is another critical issue that has to be taken into consideration when 
developing a PPI characterization tool. It has been documented that in yeast the copy 
number of different proteins could vary from 32 to 500,000 copies per cell, equivalent to 
about 30pM to 500nM considering the average size of yeast cells (Gavin et al, 2006). So 
our next experiment was to evaluate the effectiveness of pQM based photoaffinity 
labeling method with various concentrations of the target protein. The experiment was 
carried out by using conditions similar to the DTT titrations assay. But this time different 
concentrations of catPTP1Bm (0.1nM to 1000nM) were added to each reaction mixture, 
while DTT concentration was fixed to 0.1mM DTT. After the reaction, samples were also 
analyzed by Western blotting and Coomassive blue staining. In the end, it was found that 
even at 0.1nM, the catPTP1Bm band was still clearly visible (see Figure 2.10), indicating 
that minute amount of catPTP1Bm could be labeled by the peptide probe through this 








Figure 2. 10 Protein concentration effect on pQM based photoaffinity labeling. 
This experiment used the same deprotection condition as the DTT titration assay to test 
the performance of the method with different concentrations of target protein catPTP1Bm. 
Protein concentrations were changed from 1µM to 0.1nM, which covered most of the 
physiological protein concentrations. With protein concentration reducing in the system, 
the crosslink signal decreased accordingly. Even though the protein concentration was as 
low as 0.1nM, there was still a clear crosslinked band. 
 
Mapping crosslink sites for pQM based photoaffinity labeling 
Chemical crosslinking has long been used as a tool to explore the protein structure and 
PPI binding interface. Although the resolution may not be as high as X-ray 
crystallography or NMR (Jin Lee, 2008; Sinz, 2006), its ability to characterize protein 
structure and function in physiological condition makes it a useful tool. For example, 
chemical crosslinking combined with MS analysis has been used to study conformational 
change of kinase Akt during its activation (Huang & Kim, 2006) and calmodulin-melittin 





examples, it would be very interesting to analyze the crosslinking sites on the target 
protein after photoaffinity labeling with our method. We wanted to see whether pQM 
based photoaffinity labeling strategy could provide useful structure information about 
protein-peptide recognition. In the mean time, if we could identify the crosslinking site, 
specifically, the crosslinked amino acid, we would have a better understanding to the 
photoaffinity labeling procedure and mechanism. 
 
To map the protein crosslink site, MS analysis was carried out after the photoaffinity 
labeling of the target protein with the same procedure as before. Briefly, a mixture of 
1µM catPTP1Bm protein, 1 µM peptide, 1µg/µl cell lysate and 100µM DTT was used for 
the photoaffinity labeling reaction. The sample was then denatured by urea, reduced by 
TCEP, alkylated by bromoacetamide and digested by trypsin. Next, the biotin containing 
peptides were enriched by monomeric avidin resin and cleaved by acid, which 
significantly reduced the size of the crosslinking peptide. In the end, the peptide sample 
was analyzed by MS. According to the experiment design (see Figure 2.7), the peptide 








Figure 2. 11 Enriched peptides from the photoaffinity labeling experiment. 
Protein catPTP1Bm was crosslinked with the same as those for DTT titration assay 
except that DTT concentration was fixed to 100µM. After deprotection, samples were 
pretreated, digested, enriched, cleaved and analyzed. MS result showed two peptides (#1 
and #2) carried the crosslink footprint (the structure was shown inside), which was 
217.13D and generated after acid cleavage. Besides, two peptides without the marker (#1' 


















which was derived from the cleaved probe. To our interest, two peptides from 
catPTP1Bm were found bearing this marker (Figure 2.11). Tandem MS analysis revealed 
their amino acid sequence and the crosslinking sites Cys32 and Cys 121 (see Figure 
2.12): peptide#1 HEASDFPC*R (25-33, *=marker, predicted m/z=1278.57, measured 
m/z=1278.57) and peptide#2 C*AQYWPQKEEK (121-131, *=marker, predicted 
m/z=1626.78, measured m/z=1626.76, one miss cut). Surprisingly, two satellite peaks, 
peptide#1’ and peptide#2’, were found accompanying two crosslinked peptide peaks. 
Tandem MS analysis showed that they had the same amino acid sequence as peptide#1 
and peptide#2 except there was no crosslinking marker (peptide#1’ predicted 
m/z=1061.44, measured m/z=1061.44; peptide#2’ predicted m/z=1409.65, measured 
m/z=1409.65). Our explanation to this phenomenon was that the crosslinked products 
were not stable under MS condition and a fraction of peptides could be disrupted from 
the final crosslinked product by the high energy in laser beam, generating the peptides 
without 217.13Dmarker. This speculation was consistent with the reversible nature of 
QM based crosslinking, which has long been recognized and applied to DNA alkylation 
research (Rokita, 2009c). 
 
In the end, we checked the complex structure of catPTP1Bm with its substrate EGFR 
peptide 988-998 (DADEpYLIPQQG). Interestingly, it was found that two cysteine 
residues crosslinked by our peptide probe were flanking the N-terminus of the ligand 









A Precursor #1, 1278.54, 2D MS 




Figure 2. 12 mapping crosslinked 
sites with MS analysis. 
To identify the crosslinked amino acid 
residues, we used the tandem MS to 
analyze peptide precursors #1 and #2  
(in Figure 2.11). Several ions derived 
from each peptide precursor were 
found. Based on these ions, we 
unambiguously tracked the crosslinked 
sites to Cysteine 32 in peptide 
precursor #1 (A) and Cysteine 121 in 
peptide precursor #2 (B). Interestingly, 
the PTP1B-EGFR peptide complex 
structure (PDB ID: 1PTU) revealed 
that two cysteine residues were 










In this project, a photoaffinity labeling method based on pQM was developed to 
characterize protein-peptide interaction. At the beginning, the light harvest functional 
group was optimized and the amino acid residues that could be crosslinked by the 
reactive intermediate pQM were investigated. Then, the performance of this method was 
tested under different conditions. Lastly, the detailed crosslinking result was 
characterized through MS based peptide analysis. In general, this method incorporated 
cutting-edge technologies from the field of photochemistry, protein chemistry and 
reactive intermediate chemistry. It was a combination of label transfer strategy, activity 
based protein assay and traditional photoaffinity labeling, as some essential elements in 
these diverse methods were integrated in this one method.  
 
This new method significantly improved protein crosslinking specificity compared to 
other methods. Crosslinking specificity is a double-edge sword for a crosslinker. If it is 
too specific, for example, only targeting one functional group, the crosslinking efficiency 
will be very low and the method may not work in the absence of such a functional group, 
resulting false negatives. On the other hand, if it is not specific enough, everything in the 
proximity will be crosslinked, generating false positives. In our method, moderate 
reactive intermediate pQM and a thiol scavenger were combined to increase crosslinking 
specificity. It was showed that in the presence of scavengers at physiological level the 
target protein spiked in cell lysate could be specifically crosslinked (Figure 2.9). This 
result was consistent with previous reports about the crosslink capacity of the quinone-
derived crosslinkers on the detection of protein-protein recognition(Liu et al, 2007; Liu et 





pQM identified several crosslinked peptides from the target protein PTP1B, which were 
randomly distributed on the protein surface. In contrast to that report, our new method 
identified two peptides flanking the protein-peptide binding interface. More importantly, 
based on the complex structure of catPTP1Bm and EGFR peptide, we found that the 
distances between the N-terminal of the peptide and Cys32 and Cys121 on catPTP1Bm 
were 20.7 Å and 21.1 Å respectively, while our compound with the acid cleavable linker 
could extend about 21.05 Å from the N-terminal of the peptide. The consistency of these 
distances strongly suggested that our crosslinker could specifically label the target 
residue within the proximity. We thus argued that this method might be useful for the 
characterization of protein-peptide binding interface, representing a significant 
improvement on analyzing protein complex structure. After a detailed comparison 
between our method and previously reported method, it was reasoned that the different 
specificity between these two studies was caused by the application of PTP1B binding 
peptide and scavenger, because they could dramatically increase the specificity of 
crosslinking.  
 
There are other interesting aspects in this research. For example, the photolysis analysis 
of photo-caging groups at different conditions revealed flexibility for different biological 
applications. Furthermore, our new phototaffinity labeling method was compatible with 
different concentrations of thiol group, which was significant given the critical role of 
GSH (thiol) in physiological conditions. Lastly, the successful application of acid 






It was particularly exciting to find that our photocaged crosslinker could completely react 
with some functional groups, such as side chains in cysteine, histidine, lysine and aspartic 
acid (see Figure 2.6). Moreover, it was found that the crosslinked peptides on cysteine 
residue could be fragmented during MS analysis (see Figure 2.11), which might become 





Chapter Three,  
Detecting Protein Interactions in Live Cells via Complementation of a Hydrolysis-
deficient β-Lactamase 
Abstract 
β-Lactamase PCA, combined with a FRET based substrate CCF2/AM, is a useful tool for 
the detection of PPI in live cells. However, the current method cannot be used in PPI 
subcellular localization and high-throughput screening. Previous work demonstrated that 
β-lactamase mutant E166N has an altered catalytic cycle that causes the protein to 
permanently attach a substrate molecule to itself via a covalent bond (Adachi et al, 1991). 
Based on this intriguing finding, it was reasoned that if the E166N β-lactamase mutant 
was used in the PCA system, the prey fusion protein could be covalently labeled. 
Furthermore, if CCF2/AM was used as the substrate, this method could be used for PPI 
subcellular localization in live cells. In addition, if the substrate was switched to alkynyl-
penicillin, a β-lactamase substrate containing an affinity tag, this method could be used 
for high-throughput screening to identify PPIs. Because this new method featured 
covalently labeling prey protein, it was named “PCA plus”. To test the effectiveness of 
PCA plus, a series of three proof-of-concept experiments were carried out. First, an in 
vitro experiment utilizing an interacting pair of purified protein (SH3 and PPLP peptide) 
showed that N-terminus of β-lactamase with the E166N mutation could be labeled by 
substrates fluorescein-penicillin and alkynyl-penicillin using the PCA procedure. Second, 
PCA plus was used in combination with fluorescence microscopy to visualize a PPI 





indicated that this application of PCA plus could be useful for subcellular localization of 
PPIs. Third, PCA plus was utilized as an approach for covalent tagging of prey protein 
with a small molecule that enabled easy and quick enrichment strategies in preparation 
for LC-MS/MS. In conclusion, the results described here demonstrate that PCA plus is a 
useful method, in particular because it enables high resolution imaging of PPIs in live 
cells and because it can be applied to high-throughput PPI screening. These advances 
could make PCA plus a valuable tool for future PPI studies. 
 
Introduction 
The concept of PCA plus 
β-Lactamase based PCA has been well established, and its advantages in characterizing 
PPIs have been demonstrated in many applications. For example, this method was used to 
screen for inhibitors that disrupt the interaction between TLR4 and Myd88 (Lee et al, 
2007). In another application, β-lactamase based PCA mapped the binding domain 
between herpesvirus protein UL34 and UL31 family members (Schnee et al, 2006). Yet 
another example of applying this method is differentiating two types of antibodies against 
herpes simplex virus (HSV) (Fry et al, 2008). These examples clearly showed that β-
lactamase based PCA is a reliable and versatile method for the study of protein 
interactions. However, because complemented β-lactamase can quickly hydrolyze many 
substrate molecules, which can quickly diffuse throughout a cell, this method is useless in 
PPI subcellular localization. Another limitation of the current version of PCA is that it is 
very difficult for high-throughput PPI screening. We devised a modified version of PCA 





covalent labeling of the prey protein with a tag. This approach is made possible by using 
a mutant version of β-lactamase in which the active site is affected by a E166N 
mutation(Adachi et al, 1991). 
 
β-Lactamase is a serine-based hydrolase. It can hydrolyze the β-lactam ring in penicillin 
through a two-step reaction: acylation and deacylation (See Figure 1.6). During the 
acylation reaction, the enzyme and the substrate firstly associate with each other. The 
Ser70 in the enzyme catalytic center attacks the β-lactam carbonyl carbon to form a 
tetrahedral intermediate. Consequently, the four-member β-lactam ring opens and an 
acyl-enzyme complex is generated through the covalent bond between the Oγ atom of 
Ser70 and carbonyl carbon in the open β-lactam ring. During the subsequent deacylation 
reaction, a water molecule, activated by the side chain of Glu166, breaks the covalent 
bond bridging the enzyme and the product. The enzyme is thus recycled, product released 










Figure 3. 1 Overview of PCA plus method. 
Prey and bait protein are represented by the gray and white cylinder respectively. They 
are fused with the N- and C-terminal of the β-lactamase (yellow and blue structure in this 
Figure). The tag is shown as a bright yellow box. See text for the detailed description 
about the principle. 
 
 
As we can see from the β-lactamase enzymatic reaction, there is an enzyme-substrate 
intermediate bridged by a covalent bond. Interestingly, in a site-directed mutation study, 
it was found that β-lactamase with the E166N mutation could stabilize the enzyme-
substrate intermediate, that is, the mutated enzyme could be conjugated by its substrate 
(Adachi et al, 1991). If we use β-lactamase E166N mutant in the PCA system, a 
penicillin molecule will be conjugated to the prey protein through the N-terminal of β-
lactamase (E166N) after the PCA reaction. Furthermore, if we add a tag to penicillin and 
use it as the substrate in the PCA reaction, we can covalently label the prey protein 





the tag to image PPI or enrich the prey and identify it.  Because this method features 
covalently adding a tag to the target protein through the PCA reaction, it was named 
“PCA plus” (Figure 3.1).  
 
To summarize the PCA plus method design: just like many other PPI detecting tools, 
PCA plus is built on reporter protein splitting and protein fusion technology. Here, the 
reporter protein, the enzyme β-lactamase, is split into N and C terminal segments fused to 
the bait and prey proteins respectively. As shown Figure 3.1, the bait and the prey 
proteins interact and bring the N and C terminal of the β-lactamase into proximity, which 
in turn fold to form an active enzyme. After the enzymatic reaction, the bait and the prey 
protein may dissociate and separate the β-lactamase N- and C- terminal fragments. PCA 
plus uses the hydrolysis deficient β-lactamase E166N, which can be labeled by a 
substrate molecule through a stable covalent bond. So after the bait-prey interaction, a tag 
derived from β-lactamase substrate will be attached to the fusion prey protein, leaving a 
permanent marker on the prey to record the PPI event. In PPI live cell imaging mode, the 
tag will be a fluorescent dye, which can be visualized to track the target protein in live 
cells and reveal protein dynamics. In PPI high-throughput screening mode, the tag will be 
an affinity label moiety, which can facilitate enrichment/purification of the target protein 
to enable identification (eg. by MS). Notably, although in this research β-lactamase is 
used as a PCA plus prototype model due to some exceptional properties with this enzyme 
and the great flexibility of its substrates, many other reporters can be used for the same 





PCA plus for PPI live cell imaging 
β-Lactamase PCA is a PPI imaging method and the application of β-lactamase substrate 
CCF2/AM has made it a great success. For us, it was a natural choice to use the PCA plus 
for PPI imaging because this new method had two remarkable features compared to 
conventional PCA. Firstly, PCA plus could be used for PPI subcellular localization. 
Because a hydrolysis-deficient β-lactamase would be used in the PCA plus system, only 
one fluorescent substrate molecule could be hydrolyzed and consequently conjugated to 
the prey protein, generating a footprint of PPI on the prey protein. Secondly, this method 
could track the movement of the prey target protein after PPI event in live cells, which 
may be even more interesting than PPI detection, as revealing PPI function is our 
ultimate goal for a PPI study. 
PCA plus for interacting protein enrichment and “Click Chemistry” 
The PCA plus method featured the covalent label of interacting protein with a tag, which 
could be used for target protein enrichment. There were several requirements for this 
affinity tag. Firstly, the tag should have a minimal effect on the β-lactamase enzymatic 
reaction. Secondly, the tag should be small and cell permeable in order to be used as an in 
vivo labeling reagent. Thirdly, the tag should greatly facilitate down-stream protein 
enrichment. More specifically, the tag must be compatible with harsh wash conditions 
during affinity purification, including wash with detergent, organic solvent and other 
denaturing reagents. Lastly, the tag should be stable and easy to synthesize, purify and 
manipulate. After a careful search, we focused on an alkyne tag based on the “Click 
Chemistry”, because we especially favored the Huisgen’s 1,3-dipolar cycloaddition 








Figure 3. 2 "Click Chemistry" enrichment of labeled protein. 
"Click Chemistry" is a class of chemical reactions that are powerful, highly reliable, 
selective and easy to do. The most widely used "Click" reaction is Huisgen 1,3-dipolar 
cycloaddition between alkynes and azides to form 1,4-disubsituted-1,2,3-triazoles using 
Cu(I) as catalyst. Shown here is the scheme of its application on protein enrichment. 
 
 
There are several advantages to use alkyne and azide based “Click Chemistry” in our 
system. Firstly, azide and alkyne are stable and easy to be installed to other compounds. 
Secondly, the “Click” reaction is quick, specific and can proceed to completion in 
aqueous solution when supplemented with a catalyst of Cu(I). Actually, water molecule 
plays an important role in this reaction and is indispensable (Rostovtsev et al, 2002). 
Thirdly, the reaction product 1,2,3-triazole is very stable because it forms a rigid linking 
unit like a peptide bond (Bock et al, 2006; Kolb & Sharpless, 2003). Based on this 
information, we thought that alkyne and azide based “Click” reaction was a good system 
for protein enrichment and it would be our choice of the tag for in vivo interacting protein 
labeling and in vitro protein enrichment. 
 
In summary, we have laid out a plan for the development of an in vivo labeling strategy 
for PPI characterization. We would take advantage of β-lactamase based PCA and 
introduce the mutation E166N to the N-terminal fragment of β-lactamase in the system. 
Subsequently, we would use cell permeable substrates, CCF2/AM or alkynyl-penicillin, 
to test the PCA plus in live cells, through which either a fluorescent compound or an 





or protein enrichment and identification. 
Materials and methods 
Critical compounds 
β-lactamase substrate fluorescein-ampicillin, alkynyl-penicillin, alkynyl-penicillin cell 
permeable derivate (CP-AM), and azide beads for protein enrichment were synthesized 
by Dr. Junxiang Zhang in Li lab, and their molecular weight, structure and chemical 
properties were confirmed by appropriate methods accordingly. For detailed synthesis 
information, please check reference(Jiang et al, 2010) 
Gene mutation and plasmid construction 
Plasmid for the expression of β-lactamase with E166N mutation: Full-length β-lactamase 
gene was amplified with primer Nde-lac-5end and Xho-lac-3end from plasmid pDEST14. 
E166N mutation was introduced by three PCR reactions: PCR1 with primer pair OSL109 
and Xho-lac-3end, PCR2 with primer pair OSL110 and Nde-lac-5end. Subsequently, 
PCR products from both reactions were gel purified (Qiagen). PCR3 was conducted by 
combining purified PCR1 and PCR2 product as the templates with primer pair Nde-lac-
5end and Xho-lac-3end. Subsequently, PCR3 product was digested by restriction enzyme 
NdeI and XhoI and gel purified. All PCR reactions for plasmid construction in this 
research used high fidelity amplification system iproof (Bio-Rad). Expression vector 
pET26(b)+ was also digested by the same enzymes and purified. Generated DNA 
fragments of mutated β-lactamase gene and the vector were then ligated and transformed 
into E. coli DH5α. Positive clones were identified by colony PCR and plasmid digestion, 






Plasmid for the expression of NLacN-SH3 protein: SH3 domain coding sequence from 
yeast gene Sho1p was codon-optimized for E. coli. expression and a serial of 5 primers 
OSL082, OSL083, OSL084, OSL085 and OSL086 were synthesized to cover the 
modified gene. PCR reactions were used to join these primers to obtain whole SH3 
domain DNA fragment. NLacN fragment was generated by PCR reaction with primer 
OSL020 and OSL039 from β-lactamase (E166N) gene. Generated DNA fragment was 
further extended by two rounds of PCR reaction with primer pair OSL039-OSL111 and 
OSL039-OSL082 to join NLacN-Linker with SH3 coding DNA to obtain NLacN-SH3 
fusion gene. The fusion gene was digested by SacII and BamHI and cloned into 
pET11(c)+ derived vector with 6xHis tag and Ubiquitin gene (HisUBQ vector). 
 
Plasmid for the expression of PPLP-LacC protein: two primers OSL087 and OSL088 
were designed to cover Sho1p SH3 domain binding peptide QQIVNKPLPPLPVAGSS of 
Pbs2p protein (amino acid 88-104) (Marles et al, 2004), and codons was also optimized 
for E. coli. expression. β-lactamase C-terminal (amino acid 198-286) DNA fragment was 
amplified with primer OSL035-OSL021 and extended with primers OSL088 and OSL087 
to obtain fusion gene for SH3 binding peptide, linker and β-lactamase C-terminal, named 
PPLP-LacC. 
 
Plasmid for mammalian cell expression of Zip-NLacN and Zip-LacC: two plasmids for 
mammalian cell expression of Zip-Bla(1) and Zip-Bla(2) in vector pcDNA3.1/zeo were 
requested and received from Dr. Michnick’s lab based on their report (Galarneau et al, 





pcDNA3.1/zeo accordingly. E166N mutation was introduced into Zip-LacN plasmid by 
the same method as that for β-lactamase E166N mutation, and primers were OSL100, 
OSL109, OSL110 and OSL105. Mutated gene was cloned back into the same vector and 
obtained plasmid Zip-NLacN pcDNA3.1/zeo. In order to increase Zip-NLacN and Zip-
LacC co-expression efficiency in mammalian cells, Zip-LacC furion gene with its 
regulatory elements was transferred to the Zip-NLacN pcDNA3.1/zeo. Primers OSL136 
and OSL137 with a BglII site in each of them were used to amplify the Zip-LacC fusion 
gene with its regulatory elements. Generated DNA fragment was digested by BglII and 
inserted into the only BglII site in plasmid Zip-NLacN pcDNA3.1/zeo. In the end, we 
obtained the plasmid with two sets of regulatory elements to control the expression of 
both Zip-NLacN and Zip-LacC in one pcDNA3.1/zeo vector. After construction, E. coli 
strain DH5α was used to amplify and produce plasmids, and QIAGEN Plasmid Midi Kit 
was used to prepare highly pure plasmids for mammalian cell transfection experiment. 
 
Plasmid for mammalian cell expression of NLS-Zip-NLacN and NLS-Zip-LacC: The 
amino acid sequence of the Nuclear Localization Signal (NLS) in GCN4 protein is 
DPAALKRARNTEAARRSRARKLQRMK, which was predicted by software 
predictNLS (Cokol et al, 2000) and cNLS Mapper (Kosugi et al, 2009). Primer OSL167 
and OSL168 were used to generate the fusion gene with this NLS. Specifically, primer 
OSL168 and OSL105 (BGH reverse primer) was firstly used to amplify the Zip-NLacN 
and Zip-LacC fusion genes. OSL167 and OSL105 were used as the second round of PCR 
to obtain the fusion gene NLS-Zip-NLacN and NLS-Zip-LacC and add restriction site 





These two plasmids were further combined to make one plasmid that expressed both 
NLS-Zip-NLacN and NLS-Zip-LacC in mammalian cells. The plasmid construction 
procedure was exactly the same as mentioned above. 
Protein expression and purification 
Proteins were expressed in E. coli. Strain BL21 (DE3). Plasmid was transformed into 
competent cells, and bacterial cells were grown overnight on plates with appropriate 
antibiotics. Next day, bacterial cells were inoculated into LB media with antibiotics. Cell 
density was determined by measuring OD600. When it reached 0.6, isopropyl-β-D-
thiogalactopyranoside (IPTG) was added to a finial concentration of 1mM. Cells were 
allowed to grow for additional 3 hours and then collected and stored at -70oC for future 
use. 
 
For protein purification, bacterial pellet was thawed at room temperature, and Bugbuster 
(Novagen) was added to break down cells according to manufacturer’s instruction. Cell 
lysate was centrifuged at 40,000g and supernatant was kept for purification. Ni-resin 
(Bio-Rad) was used to purify these proteins according to the instruction. Briefly, cell 
lysate was diluted with 3 volumes of binding solution (50mM Tris buffer, pH7.5, 500mM 
NaCl, 5mM imidazole) and loaded to Ni column equilibrated with large amount of 
binding solution. Column was rotated at 4oC to allow the binding to occur in batch mode. 
The column was then washed intensively with wash buffer (50mM Tris buffer, pH7.5, 
500mM NaCl, 10 to 20mM imidazole). Sequentially, target protein was eluted with 
elution buffer (50mM Tris buffer, pH7.5, 500mM NaCl, 250mM imidazole), and 





against appropriate reaction buffer and concentrated by ultra-filtration tubes (Millipore). 
Protein concentration was estimated by either SDS-PAGE or Bradford assay (Sigma). 
 
Labeling β-lactamase E166N mutant with penicillin derivative substrates 
β-lactamase (E166N) was prepared as above, and the concentration was adjusted to 
10µM. Substrate fluorescein-ampicillin and alkynyl-penicillin were dissolved in DMSO 
and added to the protein solution to a final concentration of 100µM. Reactions were 
carried out at 37oC and allowed to proceed for a maximum of 3 hours. After reaction, 
protein samples in both reactions were precipitated by adding 4 volumes of cold acetone. 
For fluorescent labeling experiment, the sample was dissolved in 6M Urea and resolved 
by SDS-PAGE. Fluorescent gel imaging was conducted with a gel documentation system 
(Alpha Innotech) using UV as excitation light, after that, the gel was stained with 
Coommassive blue. For alkynyl-penicillin labeling experiment, the sample was 
resuspended in 50% acetonitrile, and 1.5µl protein sample was then mix with equal 
volume of matrix Sinapinic acid (10mg/ml) and examined with MS instrument (Applied 
Biosystem). 
 
in vitro PCA experiment with purified proteins using fluorescein-ampicillin  
For in vitro PCA experiment, purified NLacN-SH3 and PPLP-LacC proteins were mixed 
with equal molar ratio and β-lactamase substrate fluorescein-ampicillin was added to 
100µM. Two control experiments with the same concentration of NLacN-SH3 and PPLP-
LacC were also set up individually at the same time. All reactions were maintained at 





dissolved in Urea and resolved by SDS-PAGE. The same gel imaging system as 
mentioned above was used to document the signal from the PCA result, and again the gel 
was stained with Coommassive blue thereafter. 
Target protein enrichment by “Click Chemistry” method 
in vitro PCA experiment was conducted by following the same experimental procedure as 
stated above except that the substrate was change to 100µM alkynyl-penicillin. After that, 
the sample was dialyzed against 100 mM HEPES buffer, pH7.0 to remove excessive free 
substrate and change the buffer. The “Click Chemistry” reaction was carried out by using 
azide conjugated glass beads (binding capacity 136 µmol/g). In the reaction, 5mg glass 
beads were mixed with the dialyzed protein sample, and 1mM copper sulphate (CuSO4), 
1mM ascorbic acid and 0.1mM TBTA were used as a compound catalytic system. The 
reactants were mixed and rotated at room temperature for 1 hour. After the “Click” 
reaction, samples were transfered into a column and washed intensively with 2% 
CHAPS, 8M urea, and acetonitrile. In the end, the glass beads were rinsed by water and 
equilibrated with ammonium bicarbonate (40mM) and digested by trypsin (Sigma). 
Peptides generated from this experiment were analyzed by MS. 
 
Mammalian cell culture and transfection 
Human cell line Hela and HEK293T were grown in complete DMEM, supplemented 
with 10 mM HEPES, 10% fetal calf serum, 1% L-glutamine, nonessential amino acids 
(Invitrogen). Cells were grown in a 5% CO2 incubator at 37°C. One day before the 
transfection, cells were seeded to a proper density. For live cell imaging, Hela cells 





cells were used and seeded to a relatively higher density so that the next day the 
confluence could reach 90%. At the beginning of the experiment, purified plasmid 
DNA was transfected into mammalian cells by Effectene reagent (Qiagen). Briefly, 
DNA was firstly mixed with DNA-condensation buffer EC and Enhancer was added at 
a mass to volume ratio of 1:8. The sample was incubated at room temperature for 5min. 
Effectene reagent was then added to the mixture, followed by vortex for 10 seconds. 
The sample was kept at room temperature for 10min. Cells were prepared during this 
10min and fresh medium was added. After 10min incubation, transfection complex was 
first mixed with fresh media and then added to cells in a drop-wise way. After 
transfection, cells were maintained in 5% CO2 incubator at 37°C until further use. 
 
Live cell imaging with CCF2/AM substrate 
Live cell imaging was carried out with Hela cells because of their exceptional adhesive 
property and clear morphological feature. Poly-lysine coated cell culture container 
(BD) were used to grow cells. Similar transfection protocol was used as mentioned 
above but at a smaller scale proportional to the size of the cell culture chamber. 48 
hours after transfection, cells were washed with 1X HBSS (Hyclone) twice. CCF2/AM 
dissolved in DMSO was prepared by following manufacture’s instruction, and added to 
the cells at a final concentration of 1µM. Cells were kept at room temperature for 2 
hours and then examined with fluorescent microscope (Zeiss) with filter setting 






Flow cytometry experiment with live cells 
Cells transfected with PCA plus plasmid were maintained in DMEM medium 
supplemented with 10% FBS. 48 hours after transfection, cells were washed twice with 
1X PBS and digested with trypsin. After digestion, DMEM medium with 10% FBS was 
added to stop the tryptic reaction. Cells were pipetted to make single cell suspension 
and then collected by centrifuging at 200g for 5min at room temperature and washed 
with 1X HBSS twice to remove trace amount of FBS. Cell density was adjusted to 106 
cells/ml and stained by CCF2/AM at 1 µM at room temperature for 2 hours. After 
staining, cells were analyzed with FACSdiva flow cytometry instrument (BD) and 
Flowjo software was used to further process the data (Becton Dickinson, Mountain 
View, CA). 
 
Labeling and enriching the target protein in live cells  
For mammalian cell enrichment experiment, HEK293T cells were used and transfected 
with the PCA plus plasmid. When the confluence reached about 90% 24 hours after 
transfection, cells were washed with PBS, trypsinized, resuspended and seeded into 3 
volumes of the original flask. After another 24~36 hours, cells were ready for next 
experiment. Cell permeable substrate CP-AM was dissolved in DMSO and loaded to 
cells transfected with PCA plus plasmid in the same way as CCF2/AM. After 
incubating at room temperature for two hours, cells were washed once with 1X HBSS 
to remove extra substrate and then lysed in 0.5% CHAPS, 1X PBS solution on ice for 





40,000g. Target protein enrichment, digestion and identification were then carried out 
using the same protocol as in vitro PCA plus experiment stated above. 
Result 
Labeling β-lactamase E166N mutant with two substrates 
In order to carry out the PCA plus project, a new β-lactamase substrate alkynyl-penicillin 
based on the experiment design was synthesized (Jiang et al, 2010). This substrate was 
formed by conjugating alkyne group to the amine of (+)-6-aminopenicillanic acid with a 
short linker. The purpose to introduce the alkyne group was to take advantage of highly 
specific and efficient “Click Chemistry” to enrich the target protein once it was coupled 
by the substrate after the PCA plus procedure (see Figure 3.3 C). At the same time, a cell 
permeable version of this substrate (CP-AM) was synthesized by protecting the only 
carboxylic acid group through the formation of an ester bond (see Figure 3.3B), which 
made this compound permeable to cell membrane through diffusion. Once inside live 
cells, substrate precursor CP-AM could be cleaved by cytoplasmic non-specific esterase 
to form the active substrate alkynyl-penicillin. In addition, ampicillin was conjugated 
with fluorescein and got substrate fluorescein-ampicillin (Figure 3.3A), which would be 
used to visualize in vitro protein labeling. 
 
Although the alkyne group is small and β-lactamase can accommodate many different 
functional groups at this position, such as ampicillin, it was still necessary to test whether 
the E166N mutant of β-lactamase could be labeled by this substrate. So we introduced 









Figure 3. 3 Substrates for the β-lactamase PCA plus system. 
A, fluorescein-ampicillin, which contained a fluorecein molecule and β-lactam ring. This 
compound was generated by coupling fluorescein-NHS ester to the amine of Ampcillin, 
which was used to visualize the in vitro PCA plus result. B, the cell permeable version of 
alkynyl-penicillin (CP-AM). C, alkynyl-penicillin, in which an alkyne functional group 
was attached to the amine of (+)-6-Aminopenicillanic acid. D, FRET based substrate 
CCF2/AM, which is also cell permeable. This substrate contained a FRET donor and 
acceptor joined by a cephalosporin ring. Once the cephalosporin ring was cleaved by β-
lactamase, FRET acceptor would be released and quenched, allowing the emission light 


















Figure 3. 4 Labeling β-lactamase E166N by fluorescein-ampicillin. 
Mutated TEM-1 was expressed in E. coli. and purified by Ni-resin. Purified protein was 
incubated with fluorescein-ampicillin at 37oC for 3 hours and then precipitated. The 
protein sample was dissolved in urea and resolved by SDS-PAGE. The fluorescein signal 
from the protein band was captured with a gel imaging system (A) and the gel was 




enzyme (see Figure 3.4). As an initial step, we tested this mutated enzyme with substrate 
fluorescein-ampicillin. The protein was incubated with the substrate at 37oC for 3 hours, 
precipitated by pre-chilled acetone, and dissolved by 8M Urea. Subsequently, the protein 
sample was resolved by SDS-PAGE and visualized by gel documentation system. The 
result confirmed that the mutated β-lactamase could be labeled by the substrate 
fluorescein-ampicillin (See Figure 3.4).  
 
Next, we carried out the protein labeling experiment with substrate alkynyl-penicillin. 
The same β-lactamase with E166N mutation was used to incubate with alkynyl-
penicillin. After reaction, protein sample was precipitated by cold acetone at -20 oC and 
resuspended with 50% acetonitrile. At the same time, a protein sample without adding the 










Figure 3. 5 Full-length β-lactamase labeling experiment. 
MS result of full-length β-lactamase E166N alone (A) or labeled by alkynyl-penicillin 
substrate (B). Purified β-lactamase E166N was incubated with the substrate alkynyl-
penicillin at 37oC for 3hours. The sample was then precipitated by acetone, resuspended 
in 50% acetonitrile and examined by MS instrument. A control sample was also 
precipitated, resuspended and examined. For the control sample, a peak of 30090 was 
indicated on MS (A), compared to the predicted molecular mass 30087 for full-length β-
lactamase E166N as shown in. For labeled sample, MS shows a peak of 30400, compared 








E166N mutation could be labeled by alkynyl-penicillin, we used MS to analyze both 
samples (with and without adding the substrate). Our result showed that without the 
substrate, the mutated β-lactamase had a peak of 30090, compared to the predicted 
molecular weight 30087. After the labeling experiment with alkynyl-penicillin, a MS 
peak of 30400 was detected, compared to the predicted molecular weight 30397 (see 
Figure 3.5). These data demonstrated that the mutated β-lactamase with E166N could be 
labeled with modified substrate fluorescein-ampicillin and alkynyl-penicillin, which 
cleared the way for us to further study PCA plus with these substrates. 
 
in vitro PCA plus using a PPI model between SH3 domain and its binding peptide 
in vitro experiment could provide critical information about a biochemical reaction, so 
we carried out in vitro PCA plus experiment with a well characterized PPI model: the 
SH3 domain from yeast protein Sho1p (amino acid 302-367) and its binding peptide 
QQIVNKPLPPLPVAGSS from protein Pbs2p (amino acid 88-104)(Marles et al, 2004). 
This SH3 domain was quite small with just 66 amino acids. A serial of primers were 
synthesized to cover the SH3 domain and used for PCR to join these primers to obtain the 
SH3 domain coding sequence. We also made the mutation E166N and M184T in the N-
terminal fragment (corresponding to amino acid 23-196) of TEM-1 β-lactamase as 
E166N is a hydrolysis-deficient mutation and M184T can increase the enzyme activity 
and stability(Galarneau et al, 2002). This mutated N-terminal fragment of TEM-1 β-
lactamase was named NLacN. We then joined the coding sequence of SH3 domain and 
the NLacN by a flexible linker (G4S)3 to obtain NLacN-SH3. At the same time, another 







Figure 3. 6 in vitro PCA plus with substrate fluorescein-ampicillin. 
This experiment was carried out with an interacting model SH3 domain and its binding 
peptide. Fluorescein-ampicillin was used as the substrate. Fusion proteins NLacN-SH3 
and PPLP-LacC were expressed and purified. A serial of three reactions were set up for 
the in vitro PCA plus experiment: NLacN-SH3 and PPLP-LacC (lane 1), PPLP-LacC 
alone (lane 2) and NLacN-SH3 alone (lane3). All samples were incubated with 
fluorescein-ampicillin at 37oC for three hours. After reaction, samples were precipitated 
by acetone, dissolved in Urea and resolved by SDS-PAGE. Fluorescein imaging was 
firstly carried out with a UV gel documentation system (A) and the gel was then stained 
with Coomassie blue (B).  
 
(QQIVNKPLPPLPVAGSS), which was then added to the C-terminal fragment 
(corresponding to amino acid 198-286) of TEM-1 β-lactamase. Also, we introduced a 
flexible linker between these two coding sequences and got PPLP-LacC. We cloned 
NLacN-SH3 and PPLP-LacC into expression vectors, expressed both proteins in E. coli 
and purified them with Ni column. 
 
Next, we used the substrate fluorescein-ampicillin to test PCA plus method in vitro (see 
Figure 3.6). Individual protein NLacN-SH3 or PPLP-LacC or both of them were 
incubated with the substrate at 37oC for 3 hours. They were then precipitated by cold 
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light to visualize the fluorescein labeled protein band and then stained with Coomassive 
blue. Our result showed that the target protein NLacN-SH3 could be labeled by 
fluorescein-ampicillin when mixed with PPLP-LacC protein, while either NLacN-SH3 or 
PPLP-LacC could not be labeled (see Figure 3.6). This result demonstrated that the PCA 
plus could be used to label the target protein in an in vitro system. 
 
At the same time, we tested the substrate alkynyl-penicillin with the in vitro PCA plus 
using the same experiment procedure as fluorescein-ampicillin. Instead of visualizing the 
protein labeling with fluorescent gel imaging system, we used MS to analyze these 
samples. Our data showed that in the presence of both NLacN-SH3 and PPLP-LacC 
protein, the substrate alkynyl-penicillin could be successfully conjugated to the target 
protein NLacN-SH3 and generated a MS peak of 37623, compared to a predicted 
molecular weight of 37624 (see Figure 3.7A), which was the molecular weight of 
NLacN-SH3 (MW=37313) plus alkynyl-penicillin (MW=310). On the contrary, 
individual protein NLacN-SH3 or PPLP-LacC alone could not be labeled, and their MS 
peaks were 37313 and 22014 respectively, compared to predicted molecular weight 








Figure 3. 7 in vitro PCA plus with alkynyl-penicillin to label the target protein. 
Purified protein NLacN-SH3 and PPLP-LacC mixture (A), PPLP-LacC alone (B), and 
NLacN-SH3 alone (C) were used to incubate with substrate alkynyl-penicillin in 3 
parallel reactions. After labeling, protein samples were concentrated and examined by 
MS. In this result, only in the presence of both NLacN-SH3 and PPLP-LacC proteins, the 
NLacN-SH3 could be labeled by the substrate, generating a peak of 37623 (A), and we 
could see PPLP-LacC and labeled NLacN-SH3 peaks in (A); while NLacN-SH3 alone 












The purpose to use alkynyl-penicillin substrate was to facilitate target protein enrichment 
after it was labeled through the PCA plus method. To test this enrichment method, we 
prepared glass beads with azide functional groups on the surface. With this tool in hand, 
we used “Click Chemistry” to enrich protein labeled through in vitro PCA plus 
experiment. In the “Click” reaction, 1mM copper sulphate (CuSO4) was reduced by 1mM 
ascorbic acid to generate Cu (I), which was further stabilized by TBTA and used as 
catalyst for protein enrichment. After the Huisgen cyclization “Click” reaction, the glass 
beads were washed with non-denaturing detergent CHAPS (2%), denaturing reagent urea 
(8M) and acetonitrile. In the end, the glass beads were equilibrated with ammonium 
bicarbonate (40mM) and digested by Trypsin, and peptides were analyzed by MS 
instrument. Notably, it was benefited from the specific, efficient and robust “Click 
Chemistry” that we were able to immobilize the target protein with the glass beads and 
carried out on-column digestion. The first dimension of MS analysis showed that there 
were several peaks that matched predicted peptides from the target protein, and further 
MS/MS analysis confirmed their sequences (see Figure 3. 8A and B). 
 
Here we tested the in vitro PCA plus method with purified protein by using substrates 
fluorescent-ampicillin and alkynyl-penicillin. Our data showed that the fusion protein 
could be labeled by both substrates after going through the PCA plus procedure, and our 
protein gel imaging, protein enrichment, digestion and peptide MS analysis provided 









Figure 3. 8 MS analysis of enriched peptides from “Click Chemistry”. 
Target protein was labeled with substrate alkynyl-penicillin in an in vitro PCA plus 
experiment. The reaction condition was the same as protein labeling with substrate 
fluorescein-ampicillin. Glass beads coated with azide were then used to enrich labeled 
protein. In the end, the purified protein was digested and examined by MS instrument. A, 
MS of peptides derived from the enriched protein NLacN-SH3. Inlets show two peptide 
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PPI live cell imaging with PCA plus 
TEM-1 β-lactamase PCA was first developed as a PPI imaging tool using FRET-based 
substrate CCF2/AM. However, once refolded during PCA, one active β-lactamase 
molecule can hydrolyze many substrate molecules. As a result, these hydrolyzed 
substrate molecules can diffuse to all over the cell, making it impossible to localize PPI 
with subcellular resolution, which actually is a very important goal for many PPI studies. 
With the new design of the PCA plus, it would be a totally different story. Because the N-
terminal fragment of TEM-1 β-lactamase with E166N mutation can site-specifically 
couple the substrate molecule during the PCA plus reaction, thus label itself with a 
fluorescent dye when CCF2/AM is used as the substrate, enabling PPI live cell imaging 
with subcellular resolution. 
 
We conducted live cell imaging with the same PPI pair used by those who firstly 
developed TEM-1 β-lactamase PCA. Two plasmids for the expression of fusion proteins 
Zip-NLacN and Zip-LacC in mammalian cell expression vector pcDNA3.1/Zeo were 
provided by Dr. Michnick’s lab. “Zip” was a leucine zipper homodimerization domain 
coming from yeast transcription factor GCN4. We introduced the E166N mutation to the 
Zip-LacN fusion gene and obtained plasmid Zip-NLacN pcDNA3.1/zeo. Firstly, we 
transiently transfected plasmid Zip-NLacN pcDNA3.1/zeo and plasmid Zip-LacC 
pcDNA3.1/zeo into Hela cells, after 48 hours, cells were washed and incubated with 
substrate CCF2/AM for 2 hours at room temperature. Fluorescent microscopy 
examination found there were positive cells that showed blue fluorescent signal but the 





plasmids might result in a low chance for both fusion proteins Zip-NLacN and Zip-LacC 
to be co-expressed in the same cell and thus lower PCA plus efficiency. To overcome this 
problem, we transferred the Zip-LacC fusion gene and its expression control cassette to 
the plasmid Zip-NLacN pcDNA3.1/Zeo. Theoretically, this single plasmid would express 
two fusion proteins at the same time and same level when introduced into mammalian 
cells. We transfected this single plasmid into mammalian cells. After following the same 
protocol for imaging, we found the live cell PPI imaging result was significantly 
improved (See actual result in Figure 3.9C), while our control cells transfected with only 
Zip-NLacN pcDNA3.1/Zeo plasmid or empty vector plasmid showed no significant 








Figure 3. 9 PCA plus live cell imaging with a PPI model. 
Hela cell line was used for imaging. 48 hours after transfection, cells were stained with 
CCF2/AM and imaged with fluorescent microscope. A, negative control group 
transfected with plasmid vector pcDNA3.1/zeo; B, negative control group transfected 
with plasmid expressing Zip-NLacN alone; C, experiment group transfected with plasmid 
expressing ZIP-NLacN and ZIP-LacC. In each group, three pictures were taken using the 
settings for DIC, green fluorescent signal and blue fluorescent signal. The microscope 
objective is set at 40X. For control group A and B, no significant blue fluorescent signal 
was observed, while in experiment group transfected with the plasmid expressing Zip-
NLacN and Zip-LacC proteins, clear blue signal was observed. This result demonstrated 














To further characterize the PCA plus imaging result, we used flow cytometry to measure 
the fluorescent color and intensity change. In FACS assay, we set up a serial of control 
groups including plasmid vector pcDNA3.1/Zeo transfection and Zip-NLacN 
pcDNA3.1/Zeo plasmid transfection. In the experimental group we used the single 
plasmid construct to express both Zip-NLacN and Zip-LacC proteins. Moreover, we 
transfected different amount of plasmid DNA (0.25, 0.5 and 1 µg) to test the influence of 
protein expression level on the efficiency of PCA plus result. For all control groups, we 
did not see fluorescent signal change on both intensity and color (see Figure 3.10). For 
experimental groups transfected with plasmid co-expressing fusion protein Zip-NLacN 
and Zip-LacC, significant amount of cells shift toward higher blue signal, while green 
signal level was the same. More interestingly, with the increase of DNA amount 
transfected (0.25, 0.5 and 1 µg), cells showing blue fluorescent signal increased 
accordingly (15.7%, 28.1%, 38.7%) (Figure 3.10). Taken together, our experiment result 
showed that PCA plus assay was working with current mammalian cell model, and it was 




























































































































































































































































































































































































































































































































































































































PCA plus can image PPI with subcellular resolution 
Protein spatial localization is an important regulatory mechanism in many biological 
processes, and PPI localization is even more critical for studying protein cellular 
functions. On the other hand, PPIs are dynamic events inside a cell. So it will be very 
useful if a tool can readily reveal these critical characters of PPIs without using costly 
instrument and highly specialized technologies like single molecule imaging or NMR. 
Although the PCA plus method hold the potential for both PPI live cell imaging with 
subcellular resolution and PPI dynamic imaging, here we wanted to first demonstrate that 
we could image PPI in a specific organelle, that is, PPI subcellular localization. 
 
In order to test whether the PCA plus could localize PPI in an organelle, we added a 
Nuclear Localization Signal (NLS) to our PCA plus model Zip-NLacN and Zip-LacC. A 
sequence analysis revealed that yeast GCN4 protein has a NLS element, which is 
DPAALKRARNTEAARRSRARKLQRMK. We synthesized primers to add this NLS to 
the fusion protein Zip-NLacN and Zip-LacC to obtain NLS-Zip-NLacN and NLS-Zip-
LacC. As always, we constructed one plasmid for the expression of NLS-Zip-NLacN and 
NLS-Zip-LacC. In this plasmid, each fusion gene was controlled by an individual CMV 
promoter. We transfected this plasmid into Hela cells and followed the same experiment 
procedure for CCF2/AM imaging as mentioned above. Interestingly, we indeed observed 
that cells showed blue signal in a subcellular organelle when transfected with NLS-Zip-
NLacN and NLS-Zip-LacC expression plasmid (See Figure 3.11C), while control cells 
showed no significant signal in any specific subcellular position (See Figure 3.11A and 






Figure 3.11 Nuclear PPI 
imaged by PCA plus 
method in live cells with 
CCF2/AM. 
Live cell imaging was 
carried out with the 
proteins with NLS 
expressed in Hela cells. 
A, cells transfected with 
only plasmid vector; B, 
cells transfected with 
plasmid for the expression 
of NLS-Zip-NLacN only; 
C, cells transfected with 
plasmid expressing both 
NLS-Zip-NLacN and 
NLS-Zip-LacC. For each 
experiment group, three 
pictures were taken for 
green fluorescent (1), blue 
fluorescent signal (2), and 
DIC (3), followed by a 
merge of all three 
channels (4). As a result, 
we can only see blue 
fluorescent signal from 
the group C. Most 
importantly, the blue 
signal is limited to a small 
area of the cell, showing 
subcellular localization of 
leucine zipper domain 
(Zip) dimerization inside 

























The PCA plus method can enrich interacting protein from live cells 
High-throughput and high-fidelity characterization of PPI events is an ultimate goal for 
the development of a PPI study tool. However, conventional PCA systems have seldom 
been used for high-throughput PPI screening in live mammalian cells despite their 
advantage of detecting PPI under physiological conditions. That might suggest there are 
some limitations that hindered this method from the high-throughput applications. On the 
contrary, the PCA plus method should label the interacting protein with an affinity tag, 
which would make it feasible to enrich the target protein by affinity purification. When 
combined with powerful LC-MS/MS system, hopefully, this method could realize high-
throughput PPI screening in mammalian cells. 
 
In order to demonstrate that the PCA plus was potential for high-throughput PPI 
screening, we carried out in vivo labeling, in vitro pull-down and MS identification 
experiments with this method. We transfected the plasmid to express both Zip-NLacC 
and Zip-LacC proteins in mammalian cells. After 48 hours, cells were loaded with cell 
permeable substrate CP-AM (alkynyl-penicillin), in which a protection Group 
(Acetoxymethyl) was used to block the carboxylic acid group in penicillin (See Figure 
3.3). Two hours later, substrate was removed by an extensive wash and cells were lysed 
on ice by adding lysis buffer (PBS, 0.5% CHAPS). Next, target proteins were enriched by 
following “Click Chemistry” protocol: incubating the sample with azide beads in the 
presence of 1mM ascorbic acid, 1mM Copper (II) sulfate and 0.5mM TBTA at room 
temperature for 1 hour. The beads were then thoroughly washed and proteins were 





peptides generated from the enrichment and the target peptides were identified by 
searching the database with Mascot. 
 
Interestingly, our LC-MS/MS result showed that several peptides from the target protein 
Zip-NLacN were identified (See Figure 3.12C). The tandem MS spectrum of one of these 
peptides, IDAGQEQLGR was illustrated (Figure 3.12 B). More importantly, a peptide 
“NYHLENEVAR” from the leucine zipper domain was also identified (See Figure 
3.12C). In this experiment, we demonstrated that PCA plus method could be used to label 
and enrich interacting proteins from live cells, and it was compatible with proteomics 
method for protein identification. Although this was a proof-of-concept experiment and 
there is a long way to go for high-throughput library screening, we were encouraged by 
























Figure 3. 12 Interacting protein enrichment and identification with PCA plus. 
A, a scheme of the experimental procedure. Cells were first transfected with plasmid to 
express protein Zip-NLacN and Zip-LacC. Subsequently, substrate CP-AM was loaded 
followed by cell lysis and protein enrichment through "Click Chemistry". In the end, 
target protein was digested and peptides were analyzed by LC-MS/MS. B, LC graph for 
the peptides obtained from enriched protein sample. C, Tandem MS spectrum generated 
from one of the peptides. The spectrum was consistent with manual fragmentation of 
peptide "IDAGQEQLGR", and b- and y- ions were labeled. D, Amino acid sequence of 
Zip-NLacN. Tryptic peptides identified by LC-MS/MS and Mascot were colored in red. 
The sequence in the box was from leucine zipper domain, and a peptide from this domain 







In this project, a new method “the PCA plus” was developed based on β-lactamase PCA 
strategy to address challenges for PPI characterization. By introducing a point mutation 
E166N to the N-terminus of β-lactamase, the PCA method was modified to enable 
subcellular PPI localization and MS based PPI screening. In addition, the new method 
has the potential to detect low affinity and transient PPIs.  
 
The concept of the PCA plus was firstly demonstrated by an in vitro experiment. Purified 
fusion proteins NLacN-SH3 and PPLP-LacC were used to react with two penicillin-
derived substrates, fluorescein-ampicillin and alkynyl-penicillin. After the PCA plus 
procedure, the prey protein NLacN-SH3 could be labeled by both substrates. This in vitro 
system was important because it provided the most direct information about this method 
compared to cell-based assays. Also, it could serve as a platform for the future 
optimization and analysis of the PCA plus strategy.  
 
After in vitro exploration, we used PCA plus to determine whether we could visualize 
homodimerization of a leucine zipper domain in live cell imaging experiments. These 
experiments took great advantage of a remarkable substrate of β-lactamase: CCF2/AM 
(See Figure3.3D). This substrate is cell permeable and can be trapped inside cells for a 
couple of days without significantly affecting cellular functions (Zlokarnik et al, 1998). 
Also, this substrate undergoes large color change to fluorescently green upon entry into 
the cell and a distinct change to fluorescently blue upon hydrolysis by β-lactamase 





mammalian cells and to visualize its covalent attachment to the prey using fluorescent 
microscopy. Flow cytometry experiments further confirmed the conclusion that bait-prey 
interaction resulted in an easy detected fluorescence signal. Subsequently, we asked a 
question: Could the PCA plus detect a PPI with specific subcellular localization. To 
answer this question, a NLS was added to the same set of fusion proteins used above and 
the PCA plus system was tested with these nuclear proteins. Interestingly, after going 
through the PCA plus imaging procedure, PPI signal was detected from a specific 
location inside a live cell. Although we did not directly demonstrate that this location 
was, in fact, the nucleus, our results are certainly consistent with this possibility and they 
suggested that PCA plus could be useful for PPI subcellular localization analysis. 
 
Lastly, the PCA plus method was tested as an approach for pulling interacting protein out 
of whole cell extracts of mammalian cells. In order to facilitate this protein affinity 
enrichment, a cell permeable substrate alkynyl-penicillin (CP-AM) was applied. Also, a 
plasmid that expressed both bait and prey fusion proteins in the same cell and at the same 
level was used. This could significantly improve the efficiency of PCA plus (Fujimoto et 
al, 2001; Lee et al, 2009). In the end, the target protein was labeled inside live cells 
through the PCA plus method, enriched by “Click Chemistry” and identified by LC-
MS/MS analysis (Figure 3.12).  
 
An underlying concern with the PCA plus method was whether sufficient protein could 
be enriched for MS analysis. In order to answer this question, a comparison between 





(Burckstummer et al, 2006), a typical TAP experiment requires 5 X 107 mammalian cells, 
equivalent to 35mg total protein with 70µg recombinant bait protein. After two rounds of 
affinity purification, about 2µg bait protein and 7µg prey proteins (0.2~4µg each) can be 
enriched. Subsequently, SDS-PAGE is used to resolve protein complex followed by 
protein band recovery and in gel digestion. There are two issues related to this procedure. 
(i), proteins are diluted during cell lysis, column wash and TEV cleavage, and are 
maintained for a long time under this condition, which can cause the protein complex to 
dissociate according to PPI kinetics. (ii), in-gel digestion can further decrease the overall 
efficiency of the method, because the yield of this step is about 20% (Kocher & Superti-
Furga, 2007). Compared to the TAP method, our PCA plus only need one step of 
purification, which is based on covalent label of target protein and highly efficient “Click 
Chemistry”. Therefore, if low efficient TAP method can enrich enough protein for MS 
analysis from mammalian cells, a more robust PCA plus method should be able to 
achieve the same goal, which has actually been demonstrated by our LC-MS/MS 













Chapter Four,  
Summary and Perspective 
PPI studies provide important information for many fields in life science research, 
including proteomics, cell biology, molecular genetics, biophysics and biochemistry. An 
ideal approach for PPI analysis would combine high fidelity and high-throughput PPI 
detection. High fidelity means detecting a PPI with physiological implications, and 
validating the physiological role of any PPI can require a lot of follow up experiments, 
that are usually the focus of hypothesis-driven projects. On the other hand, technique-
driven projects, such as genome wide PPI mapping with the Y2H system, generally focus 
on exploring the likelihood of protein association based on their physical structures but 
not on their physiological functions. High-throughput PPI detection is another important 
issue in this field. Although hypothesis-driven PPI studies are more reliable, the most 
cost-effective and timesaving manner for PPI research is still high-throughput PPI 
screening, given the huge workload for PPI network mapping. The dilemma between 
these two aspects of current PPI research must be addressed before comprehensive PPI 
network mapping is achieved. 
 
The two projects carried out in this thesis research represent our attempts to develop PPI 
tools that can provide both high fidelity and high throughput. Although both projects are 
still at their primary stages, they appear to have great potential. For the photoaffinity 
labeling project, in the future we can make use of the unnatural amino acid system to 
incorporate the photoactivable moiety into a bait protein and label its interacting proteins 





which can load an unnatural amino acid to an amber tRNA in a cell, the unnatural amino 
acid o-nitrobenzyl-tyrosine (oNBTyr) has been incorporated into a protein at the position 
corresponding to the amber nonsense codon. This approach has been used successfully to 
incorporate 15N-labeled oNBTyr into a protein to facilitate its structural analysis by NMR 
(Cellitti et al, 2008; Deiters et al, 2006). Because oNBTyr is very similar to our 
compound PC-1 (See Figure 2.3), it is very likely that we can incorporate PC-1 into a bait 
protein using the same approach. In this way, we can generate the PC-1 labeled bait 
protein in cells and use UV light to trigger its crosslinking to interacting proteins. 
Alternatively, we can make use of site-specific protein labeling technology (Chen & 
Ting, 2005) to attach PC-1 or PC-2 to a bait protein prior to crosslinking it to interacting 
partner inside a cell. Currently, there are many efficient systems available to incorporate 
small molecules into a target protein through site-specific protein labeling, such as FlAsH 
(Souza, 2007), Halo tag (Los et al, 2008), Sortase (Popp et al, 2009) and PRIME 
(Uttamapinant et al, 2010). In addition, directly adding PC-1 or PC-2 to a peptide ligand 
during synthesis and then using this ligand to characterize cell surface receptors through 
UV triggered protein crosslinking is another option for applying our photo-caging 
crosslinker. 
 
There are also many possible future applications of the PCA plus method. Firstly, we can 
apply this method for high-throughput PPI screening. Our result indicates that it is best to 
express bait-LacC and prey-NLacN in one plasmid construct to ensure equal expression 
levels of bait and prey. Thus, our starting vector would carry the bait-LacC fusion gene, 






Some practical issues for the PCA plus method are: how many cells to use and how much 
plasmid to transfect into cells. To address these issues, it might be necessary to 
systematically test different parameters before carrying out a large-scale PPI screening. 
 
Another potential future direction for our PCA plus method would be to characterize 
transient and low affinity PPIs.  These types of PPIs are not easily detected by Y2H or 
TAP methods. Because PCA plus method may covalently attach a tag to even transiently 
or weakly interacting proteins, it will be very exciting to see how it can be used to study 
these challenging PPIs. Currently, we are working on using PCA plus to identify protein 
substrates for a protein tyrosine phosphotase SHP2 (Mohi & Neel, 2007). These SHP2-
substrate protein interactions are expected to be transient. Through this effort, we hope to 
discover some new targets for SHP2, a critical protein involved in growth factor and 
integrin signaling. More importantly, in this ongoing study we set the goal to further 
develop the PCA plus and add new features to it by applying some newly designed 
substrates for β-lactamase. 
 
Although we are confident of the future application of both methods, we recognize they 
have limitations. In order to better use them in different situations, we want to clarify 
some conditions that may affect their effectiveness. For the photocrosslinking method, 
one of the concerns is self-crosslinking to the bait protein when it is applied to identify 
the unknown interacting proteins. For example, if we incorporate the PC-1 compound to 





deprotected crosslinker will conjugate the amino acid residues, especially cysteine 
residue, on the bait protein, because these amino acid residues may be closer to the 
crosslinker than those on the surface of prey proteins. To circumvent this problem, the 
location of the PC-1 in the bait protein 3-dimensional structure must be carefully 
designed to avoid positioning it next to a nucleophile group on the bait protein surface. 
Another concern for our photocrosslinking approach is the method used to load the 
photocaged crosslinker onto the bait. Although we have discussed that there are many 
available methods for achieving this goal, they all involve some chemical synthesis, for 
example loading the compound to a ligand peptide, which may hinder their use by 
laboratories lacking expertise in chemical synthesis. Our last concern about the 
crosslinking method is the stability and reversibility of the crosslinked product under MS 
conditions. Reversibility of quinone methide based crosslinking is an interesting 
phenomenon that has been widely investigated (Rokita, 2009b). From our crosslinking 
site mapping experiment, we found that a portion of crosslinked peptides from both 
crosslinked sites could shed off the crosslinking footprint during MS analysis (See Figure 
2. 11). This feature may facilitate the identification of crosslinked peptides with MS. On 
the other hand, it reminds us that the crosslinked peptide may not be stable or undergo 
reverse crosslinking under special conditions, and either possibility will cause the 
decrease of MS signal intensity and will affect the efficiency of characterizing the 
crosslinking site on the target protein. 
 
For the PCA plus method, there are also several critical issues that need special attention. 





PCA plus uses a hydrolysis deficient enzyme to label the target protein, the PPI signal 
will not be amplified in this system. On the contrary, conventional PCA systems use very 
efficient enzymes to amplify PPI signal, they are the best choice if detecting sensitivity is 
the most important requirement for a PPI study, such as the study of low abundant PPIs. 
Secondly, protein overexpression may cause false positive for the PCA plus method. This 
method is built on protein overexpression strategy for the detection of PPI inside live 
cells. This overexpression may give rise to artifacts (false positives), and this possibility 
can be even more significant when one realizes that the local concentration of 
recombinant protein in a cellular compartment may be much higher than the average 
protein concentration in a cell. Thus, if the bait and prey protein happen to be 
concentrated in the same organelle, although they are physiologically irrelevant to each 
other, the chance to generate false positive result will be increased significantly, which 
should be taken into consideration when we apply this method to PPI detections. Using a 
weaker promoter for the PCA plus method or a validation procedure after high-
throughput PPI screening may be necessary in order to solve this problem. Thirdly, 
fusion protein orientation may affect the PCA plus result and generate false negative 
results. In the PCA plus method, bait and prey will be fused to the C and N terminal of β-
lactamase respectively. It is possible that bait and prey interaction will make the two 
fragments of β-lactamase far from each other if the orientation of fusion protein is not 
appropriate. This type of false negative result can be corrected by switching the 
orientation of one of the fusion proteins. Another potential concern is that fusing a 
fragment of β-lactamase protein to one end of the target protein may interfere with its 





unhealthy cells may affect CCF2/AM de-esteration and generate strong background 
signal for live cell imaging, which is a general concern for using this substrate for β-
lactamase (Remy et al, 2007). Thus, we recommend using very healthy cells for this 
experiment (for example, low passage cells and cells with good morphological 























1. Primers used in both studies 
ID NAME SEQUENCE 
OSL109 E166NF 5’-GATCGTTGGAACCCGGAGCTG-3’  




































OSL035 LACCC BamHI 5’- GCAGCCGGATCCTTACCAATGCTTAATCAG -3'  
OSL021 LAC198C  
5’-GTGGTAGCGGTGGTGGTGGTAGCACTA 
GTCTACTTACTCTAGC -3  
OSL100 T7PROBamHI  5’-TATCGGGGATCCGAAATTAATACGACTCACTATAG-3’ 
OSL105 BGH REVERSE 5’-CTAGAAGGCACAGTCGAGGC-3’  
OSL136 2IN1F 5'-ATCGGGAGATCTCCCGATCCCCTATGG-3' 
OSL137 2INR 5’-CAGCTGAGATCTCCAGCTGGTTCTTTCCGCC-3’ 
OSL038 CATPTP1BF 5'-AAGGCTCCGCGGTGGTGAGATGGAAAAG-3' 
OSL041 CATPTP1BR 5’- CATGTGGATCCTTAATTGTGTGGCTCCAGG-3’ 
OSL042 C215S PTP1BF 5’-GTGGTGCACTCCAGTGCAG-3’ 
OSL043 C215S PTP1BR 5’- CTGCACTGGAGTGCACCAC - 3’ 
 NDE-LAC-5’ 5’-GCGGGAATTCCATATGCACCCAGAAACGCTGGTG-3’ 
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